Recent Additions

This page includes the documents that were newly added to the repository within the last 30 days.

All these words:

This exact word or phrase:

Any of these words:

None of these words:

Language:

Visit our Help Page for additional assistance

Select a Range:

Select a Format:

Custom Search Builder:

Custom Search Box

Visit our Help Page for additional assistance

Showing 201 - 220 of 1970 results

Prevalence and Burden of Asthma Among US Working Adults by Industry and Occupation-United States, 2020-2021.

Syamlal, Girija ;

Dodd, Katelynn E.

January 2025 | The Journal of Asthma: Official Journal of the Association for the Care of Asthma, 2025, v. 62, no. 1

Assess the prevalence of current asthma, asthma attacks/episodes, and asthma-related emergency room (ER) visits by industry and occupation and estimate the proportion of current asthma cases associated with employment during 2020-2021.The 2020-2021 National Health Interview Survey data for persons aged ≥18 years who were employed at any time during ...

10/10/2026

Supporting Files

Title : Prevalence and Burden of Asthma Among US Working Adults by Industry and Occupation-United States, 2020-2021. Personal Author(s) : Syamlal, Girija;Dodd, Katelynn E.;Mazurek, Jacek M.; Published Date : January 2025 Pages in Document : 73-83 (19 pdf pages) Source : The Journal of Asthma: Official Journal of the Association for the Care of Asthma, 2025, v. 62, no. 1 DOI : https://doi.org/10.1080/02770903.2024.2387751 Journal Title : The Journal of Asthma: Official Journal of the Association for the Care of Asthma
Syamlal, G., Dodd, K. E., & Mazurek, J. M. (2025). Prevalence and Burden of Asthma Among US Working Adults by Industry and Occupation-United States, 2020-2021. The Journal of Asthma: Official Journal of the Association for the Care of Asthma, 62(1). https://doi.org/10.1080/02770903.2024.2387751

Syamlal, Girija, Katelynn E. Dodd, and Jacek M. Mazurek. "Prevalence and Burden of Asthma Among US Working Adults by Industry and Occupation-United States, 2020-2021." The Journal of Asthma: Official Journal of the Association for the Care of Asthma 62, no. 1 (2025). https://doi.org/10.1080/02770903.2024.2387751.

Syamlal, Girija, et al. "Prevalence and Burden of Asthma Among US Working Adults by Industry and Occupation-United States, 2020-2021." The Journal of Asthma: Official Journal of the Association for the Care of Asthma, vol. 62, no. 1, 2025. Stacks. https://doi.org/10.1080/02770903.2024.2387751.
Export RIS Citation Information. TY - Journal Article AU - Syamlal, Girija AU - Dodd, Katelynn E. AU - Mazurek, Jacek M. AB - Assess the prevalence of current asthma, asthma attacks/episodes, and asthma-related emergency room (ER) visits by industry and occupation and estimate the proportion of current asthma cases associated with employment during 2020-2021. AB - The 2020-2021 National Health Interview Survey data for persons aged ≥18 years who were employed at any time during the 12 months prior to the interview were analyzed. AB - An estimated 12.7 million US working adults had current asthma. Of those, 40% had an asthma attack/episode and 8.6% had an asthma-related ER visit. Prevalence varied by sociodemographic characteristics, industry, and occupation. Highest asthma prevalence was among workers in the administrative, support, waste management, and remediation industry and the community and social services occupation. Nearly half of workers with current asthma in the arts, entertainment, and recreation industry and arts, design, entertainment, sports, and media occupations reported having an asthma attack/episode. Workers in the accommodations and food services industry and food preparation and serving related occupation had the highest asthma-related ER visits. The proportion of current asthma cases attributable to employment was estimated to be 9.2% by industry and 12.2% by occupation. AB - An estimated 1.2-1.5 million asthma cases among workers might be attributable to employment by industry and occupation. Disparities in asthma prevalence, asthma attacks/episodes and asthma-related ER visits among workers exist. These findings underscore the importance of early identification of asthma cases in relation to work and implementation of targeted interventions (including, training and education, personal protective equipment use, health surveillance, workplace policies), especially among workers employed in industries and occupations with elevated asthma prevalence. AB - Author manuscript AN - cdc:262067 C4 - PMC11970257 DO - https://doi.org/10.1080/02770903.2024.2387751 IS - 1 J2 - The Journal of Asthma: Official Journal of the Association for the Care of Asthma KW - Adolescent KW - Female KW - Aged KW - Young Adult KW - Employment KW - Emergency Service, Hospital KW - Socioeconomic Factors KW - Asthma KW - Prevalence KW - Industry KW - Male KW - Middle Aged KW - Occupations KW - Humans KW - Health Surveys KW - Adult KW - Asthma KW - workers KW - industry KW - occupation KW - attributable cases KW - Humans KW - Adult KW - Asthma KW - Male KW - Prevalence KW - Female KW - Middle Aged KW - Occupations KW - Young Adult KW - Adolescent KW - Industry KW - Aged KW - Emergency Service, Hospital KW - Health Surveys KW - Socioeconomic Factors KW - Employment LA - eng PY - 2025 T2 - The Journal of Asthma: Official Journal of the Association for the Care of Asthma T2 - The Journal of Asthma: Official Journal of the Association for the Care of Asthma, 2025, v. 62, no. 1 TI - Prevalence and Burden of Asthma Among US Working Adults by Industry and Occupation-United States, 2020-2021. VL - 62 UR - https://stacks.cdc.gov/view/cdc/262067 ER -
Clusters of Emerging Multidrug-resistant Organisms in US Health Care Facilities During the Initial Months of the SARS-CoV-2 Pandemic.

Ham, D. Cal ;

Li, Ruoran

December 2024 | American Journal of Infection Control, 2024, v. 52, no. 12

Outbreaks of emerging multidrug-resistant organisms (eMDROs), including carbapenem-resistant Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Candida auris, have been reported among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients. We describe eMDRO clusters in SARS-CoV-2 units and associated infection contro ...

10/10/2026

Supporting Files

Title : Clusters of Emerging Multidrug-resistant Organisms in US Health Care Facilities During the Initial Months of the SARS-CoV-2 Pandemic. Personal Author(s) : Ham, D. Cal;Li, Ruoran;Mitsunaga, Tisha;Czaja, Christopher;Prestel, Christopher;Bhaurla, Sandeep;Cumming, Melissa;Brennan, Brenda;Innes, Gabriel;Carrico, Savannah;Chan, Allison;Merengwa, Enyinnaya;Stahl, Anna;Ostrowsky, Belinda;de Perio, Marie A.;Walters, Maroya Spalding; Published Date : December 2024 Pages in Document : 1390-1396 (15 pdf pages) Source : American Journal of Infection Control, 2024, v. 52, no. 12 DOI : https://doi.org/10.1016/j.ajic.2024.07.013 Journal Title : American Journal of Infection Control
Ham, D. C., Li, R., Mitsunaga, T., Czaja, C., Prestel, C., Bhaurla, S., Cumming, M., Brennan, B., Innes, G., Carrico, S., Chan, A., Merengwa, E., Stahl, A., Ostrowsky, B., de Perio, M. A., & Walters, M. S. (2024). Clusters of Emerging Multidrug-resistant Organisms in US Health Care Facilities During the Initial Months of the SARS-CoV-2 Pandemic. American Journal of Infection Control, 52(12). https://doi.org/10.1016/j.ajic.2024.07.013

Ham, D. Cal, Ruoran Li, Tisha Mitsunaga, Christopher Czaja, Christopher Prestel, Sandeep Bhaurla, and Melissa Cumming, et al.. "Clusters of Emerging Multidrug-resistant Organisms in US Health Care Facilities During the Initial Months of the SARS-CoV-2 Pandemic." American Journal of Infection Control 52, no. 12 (2024). https://doi.org/10.1016/j.ajic.2024.07.013.

Ham, D. Cal, et al. "Clusters of Emerging Multidrug-resistant Organisms in US Health Care Facilities During the Initial Months of the SARS-CoV-2 Pandemic." American Journal of Infection Control, vol. 52, no. 12, 2024. Stacks. https://doi.org/10.1016/j.ajic.2024.07.013.
Export RIS Citation Information. TY - Journal Article AU - Ham, D. Cal AU - Li, Ruoran AU - Mitsunaga, Tisha AU - Czaja, Christopher AU - Prestel, Christopher AU - Bhaurla, Sandeep AU - Cumming, Melissa AU - Brennan, Brenda AU - Innes, Gabriel AU - Carrico, Savannah AU - Chan, Allison AU - Merengwa, Enyinnaya AU - Stahl, Anna AU - Ostrowsky, Belinda AU - de Perio, Marie A. AU - Walters, Maroya Spalding AB - Outbreaks of emerging multidrug-resistant organisms (eMDROs), including carbapenem-resistant Enterobacterales, carbapenem-resistant Acinetobacter baumannii, and Candida auris, have been reported among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients. We describe eMDRO clusters in SARS-CoV-2 units and associated infection control (IC) practices early in the SARS-CoV-2 pandemic. AB - We conducted a retrospective survey of a convenience sample of health departments in 11 states to describe clusters of eMDROs that began before November 1, 2020 and involved SARS-CoV-2 units. Cluster characteristics and IC practices during the cluster period were assessed using a standardized outbreak report form, and descriptive analyses were performed. AB - Overall, 18 eMDRO clusters (10 carbapenem-resistant Enterobacterales, 6 C auris, 1 carbapenem-resistant Pseudomonas aeruginosa, and 1 carbapenem-resistant A baumannii) in 18 health care facilities involving 397 patients were reported from 10 states. During the cluster period, 60% of facilities reported a shortage of isolation gowns, 69% extended use of gowns, and 67% reported difficulty obtaining preferred disinfectants. Reduced frequency of hand hygiene audits was reported in 85% of acute care hospitals during the cluster period compared with before the pandemic. AB - Changes in IC practices and supply shortages were identified in facilities with eMDRO outbreaks during the SARS-CoV-2 pandemic and might have contributed to eMDRO transmission. AB - Author manuscript AN - cdc:262066 C4 - PMC11771245 DO - https://doi.org/10.1016/j.ajic.2024.07.013 IS - 12 J2 - American Journal of Infection Control KW - Retrospective Studies KW - Drug Resistance, Multiple, Bacterial KW - Candida auris KW - Infection Control KW - Pandemics KW - SARS-CoV-2 KW - Humans KW - COVID-19 KW - Health Facilities KW - Acinetobacter baumannii KW - Cross Infection KW - Outbreaks KW - COVID-19 KW - Infection control KW - Humans KW - COVID-19 KW - Retrospective Studies KW - Health Facilities KW - SARS-CoV-2 KW - Infection Control KW - Drug Resistance, Multiple, Bacterial KW - Cross Infection KW - Acinetobacter baumannii KW - Candida auris KW - Pandemics LA - eng PY - 2024 T2 - American Journal of Infection Control T2 - American Journal of Infection Control, 2024, v. 52, no. 12 TI - Clusters of Emerging Multidrug-resistant Organisms in US Health Care Facilities During the Initial Months of the SARS-CoV-2 Pandemic. VL - 52 UR - https://stacks.cdc.gov/view/cdc/262066 ER -
Honesty, Communication and Trust Are What Bring Peace of Mind : Narratives of HIV Risk Among Hispanic/Latino Men Who Have Sex With Men in the Southern United States.

Gelaude, Deborah ;

Roland, Katherine B.

October 2025 | Journal of Racial and Ethnic Health Disparities, 2025, v. 12, no. 5

For Hispanic/Latino MSM (HLMSM) in the South, HIV burden remains high, and HIV elimination is a national priority. Between July and September 2016, using a strengths-based approach informed by resilience theory, we conducted qualitative interviews with HIV-negative HLMSM in five southern cities in the United States with elevated HIV prevalence. We ...

10/10/2026

Supporting Files

Title : Honesty, Communication and Trust Are What Bring Peace of Mind : Narratives of HIV Risk Among Hispanic/Latino Men Who Have Sex With Men in the Southern United States. Personal Author(s) : Gelaude, Deborah;Roland, Katherine B.;Gaul, Zaneta;Reyes, Jovanni V.;Denson, Damian J.; Published Date : October 2025 Pages in Document : 2985-2993 (16 pdf pages) Source : Journal of Racial and Ethnic Health Disparities, 2025, v. 12, no. 5 DOI : https://doi.org/10.1007/s40615-024-02106-w Journal Title : Journal of Racial and Ethnic Health Disparities
Gelaude, D., Roland, K. B., Gaul, Z., Reyes, J. V., & Denson, D. J. (2025). Honesty, Communication and Trust Are What Bring Peace of Mind : Narratives of HIV Risk Among Hispanic/Latino Men Who Have Sex With Men in the Southern United States. Journal of Racial and Ethnic Health Disparities, 12(5). https://doi.org/10.1007/s40615-024-02106-w

Gelaude, Deborah, Katherine B. Roland, Zaneta Gaul, Jovanni V. Reyes, and Damian J. Denson. "Honesty, Communication and Trust Are What Bring Peace of Mind : Narratives of HIV Risk Among Hispanic/Latino Men Who Have Sex With Men in the Southern United States." Journal of Racial and Ethnic Health Disparities 12, no. 5 (2025). https://doi.org/10.1007/s40615-024-02106-w.

Gelaude, Deborah, et al. "Honesty, Communication and Trust Are What Bring Peace of Mind : Narratives of HIV Risk Among Hispanic/Latino Men Who Have Sex With Men in the Southern United States." Journal of Racial and Ethnic Health Disparities, vol. 12, no. 5, 2025. Stacks. https://doi.org/10.1007/s40615-024-02106-w.
Export RIS Citation Information. TY - Journal Article AU - Gelaude, Deborah AU - Roland, Katherine B. AU - Gaul, Zaneta AU - Reyes, Jovanni V. AU - Denson, Damian J. AB - For Hispanic/Latino MSM (HLMSM) in the South, HIV burden remains high, and HIV elimination is a national priority. Between July and September 2016, using a strengths-based approach informed by resilience theory, we conducted qualitative interviews with HIV-negative HLMSM in five southern cities in the United States with elevated HIV prevalence. We analyzed data using a qualitative content analysis approach, assessing for interrater reliability. A brief behavioral survey was also conducted. We enrolled 51 HLMSM (mean age = 33 years, range = 15-63). HLMSM discussed the climate of fear about HIV and homosexuality impeding HIV prevention, including the impact of stigma and taboo. Three main strengths-based strategies emerged for preventing HIV: assessing partner risk, establishing boundaries for sexual interactions, and self-education. Future HIV prevention efforts may benefit from balancing risk-based approaches with those that emphasize resilience, address partner trustworthiness and safety, and focus on providing novel outlets for HIV prevention education. AB - Author manuscript AN - cdc:262065 C4 - PMC12363387 DO - https://doi.org/10.1007/s40615-024-02106-w IS - 5 J2 - Journal of Racial and Ethnic Health Disparities KW - Adolescent KW - White KW - Qualitative Research KW - Hispanic or Latino KW - Trust KW - Social Stigma KW - Young Adult KW - Interviews as Topic KW - Homosexuality, Male KW - Sexual Partners KW - Communication KW - Male KW - Humans KW - Middle Aged KW - Adult KW - HIV Infections KW - HIV KW - Hispanic KW - Latino KW - MSM KW - HIV prevention KW - Resilience KW - U.S. South KW - Qualitative methods KW - Humans KW - HIV Infections KW - Male KW - Adult KW - Adolescent KW - Middle Aged KW - Hispanic or Latino KW - Young Adult KW - Homosexuality, Male KW - Trust KW - Communication KW - Qualitative Research KW - Sexual Partners KW - Interviews as Topic KW - Social Stigma KW - White LA - eng PY - 2025 T2 - Journal of Racial and Ethnic Health Disparities T2 - Journal of Racial and Ethnic Health Disparities, 2025, v. 12, no. 5 TI - Honesty, Communication and Trust Are What Bring Peace of Mind : Narratives of HIV Risk Among Hispanic/Latino Men Who Have Sex With Men in the Southern United States. VL - 12 UR - https://stacks.cdc.gov/view/cdc/262065 ER -
Identifying Patients at Risk For Alcohol-Exposed Pregnancies: the Importance of Addressing Multiple Risk Factors.

McRee, Bonnie G. ;

Hanson, Bridget L.

April 2025 | Substance Use & Addiction Journal, 2025, v. 46, no. 2

The increasing prevalence of fetal alcohol spectrum disorders is a critical public health issue. Two behaviors, consuming alcohol and using less effective pregnancy prevention, may result in alcohol-exposed pregnancies (AEPs) in individuals who can become pregnant. In the context of alcohol screening and brief intervention (SBI) services, cutoff sc ...

10/10/2026

Supporting Files

Title : Identifying Patients at Risk For Alcohol-Exposed Pregnancies: the Importance of Addressing Multiple Risk Factors. Personal Author(s) : McRee, Bonnie G.;Hanson, Bridget L.;Vendetti, Janice;King, Diane K.;Pawlukiewicz, Iwona;Berry, Erin;Johnson, Jessica;Marshall, Deanna;Rosato, Lauren;Gallucci, Karen Steinberg;Whitmore, Corrie; Published Date : April 2025 Pages in Document : 452-460 (15 pdf pages) Source : Substance Use & Addiction Journal, 2025, v. 46, no. 2 DOI : https://doi.org/10.1177/29767342241267086 Journal Title : Substance Use & Addiction Journal
McRee, B. G., Hanson, B. L., Vendetti, J., King, D. K., Pawlukiewicz, I., Berry, E., Johnson, J., Marshall, D., Rosato, L., Gallucci, K. S., & Whitmore, C. (2025). Identifying Patients at Risk For Alcohol-Exposed Pregnancies: the Importance of Addressing Multiple Risk Factors. Substance Use & Addiction Journal, 46(2). https://doi.org/10.1177/29767342241267086

McRee, Bonnie G., Bridget L. Hanson, Janice Vendetti, Diane K. King, Iwona Pawlukiewicz, Erin Berry, and Jessica Johnson, et al.. "Identifying Patients at Risk For Alcohol-Exposed Pregnancies: the Importance of Addressing Multiple Risk Factors." Substance Use & Addiction Journal 46, no. 2 (2025). https://doi.org/10.1177/29767342241267086.

McRee, Bonnie G., et al. "Identifying Patients at Risk For Alcohol-Exposed Pregnancies: the Importance of Addressing Multiple Risk Factors." Substance Use & Addiction Journal, vol. 46, no. 2, 2025. Stacks. https://doi.org/10.1177/29767342241267086.
Export RIS Citation Information. TY - Journal Article AU - McRee, Bonnie G. AU - Hanson, Bridget L. AU - Vendetti, Janice AU - King, Diane K. AU - Pawlukiewicz, Iwona AU - Berry, Erin AU - Johnson, Jessica AU - Marshall, Deanna AU - Rosato, Lauren AU - Gallucci, Karen Steinberg AU - Whitmore, Corrie AB - The increasing prevalence of fetal alcohol spectrum disorders is a critical public health issue. Two behaviors, consuming alcohol and using less effective pregnancy prevention, may result in alcohol-exposed pregnancies (AEPs) in individuals who can become pregnant. In the context of alcohol screening and brief intervention (SBI) services, cutoff scores on widely used alcohol risk assessments (eg, Alcohol Use Disorders Identification Test, U.S. version [USAUDIT]) may fail to identify individuals whose relatively low alcohol consumption may still put them at risk for an AEP due to their pregnancy prevention method. AB - To identify this gap in alcohol SBI service delivery, we examined data from 2 reproductive healthcare systems implementing alcohol SBI, to explore the prevalence of individuals who met both of the following risk conditions: reported any alcohol use on the USAUDIT and a pregnancy prevention method less than 88% effective. Electronic health records for individuals aged 18 to 49 presenting for preventive care in 2021 were analyzed. AB - Of 11 567 screened, 7638 reported some alcohol use, but screened at a lower-risk level and were not flagged to receive an alcohol-focused brief intervention (BI). Of these, 1477 were using a method of pregnancy prevention that was less than 88% effective. In addition, 118 of the 1676 who screened positive on the USAUDIT were using less effective contraception and did not receive a BI. In summary, the number of individuals at risk of an AEP who did not receive an alcohol BI was 1595 (13.8%) of the total patients screened for at-risk alcohol use. AB - There is a need for system modifications to assess multiple behaviors simultaneously and alert providers when a combination of behaviors increases a specific health risk, such as an AEP. Tailored alcohol BIs that include the risks/benefits of various pregnancy prevention methods to reduce AEPs provide opportunities to enhance the reach of standard alcohol SBI services. AB - Author manuscript AN - cdc:262064 C4 - PMC11789002 DO - https://doi.org/10.1177/29767342241267086 IS - 2 J2 - Substance Use & Addiction Journal KW - Pregnancy KW - Adolescent KW - Female KW - Alcohol Drinking KW - Risk Factors KW - Fetal Alcohol Spectrum Disorders KW - Risk Assessment KW - Humans KW - Middle Aged KW - Young Adult KW - Adult KW - Alcohol Screening and Brief Intervention KW - Brief Intervention and Referral to Treatment KW - Alcohol Use Disorders Identification Test KW - Alcohol-Exposed Pregnancy KW - Fetal Alcohol Spectrum Disorders KW - Contraception Effectiveness KW - Pregnancy Prevention KW - USAUDIT KW - SBI KW - SBIRT KW - FASD KW - Screening KW - Humans KW - Female KW - Pregnancy KW - Adult KW - Risk Factors KW - Young Adult KW - Alcohol Drinking KW - Fetal Alcohol Spectrum Disorders KW - Adolescent KW - Middle Aged KW - Risk Assessment LA - eng PY - 2025 T2 - Substance Use & Addiction Journal T2 - Substance Use & Addiction Journal, 2025, v. 46, no. 2 TI - Identifying Patients at Risk For Alcohol-Exposed Pregnancies: the Importance of Addressing Multiple Risk Factors. VL - 46 UR - https://stacks.cdc.gov/view/cdc/262064 ER -
Mortality Among Children Under Five Years of Age Living With HIV on Antiretroviral Treatment From HIV Case Surveillance Data, Malawi, 2022.

Chapman, Kelly S. ;

Luhanga, Misheck

December 2024 | The Pediatric Infectious Disease Journal, 2024, v. 43, no. 12

From Malawi's HIV case surveillance, we report clinical characteristics and outcomes of 4461 children living with HIV on antiretroviral treatment <5 years old from January to December, 2022. Among the 4% of children living with HIV who died, 43% were asymptomatic, 35% had advanced or severe symptoms at the time of HIV diagnosis and 50% died within 6 months of receiving an HIV diagnosis.

10/10/2026

Supporting Files

Title : Mortality Among Children Under Five Years of Age Living With HIV on Antiretroviral Treatment From HIV Case Surveillance Data, Malawi, 2022. Personal Author(s) : Chapman, Kelly S.;Luhanga, Misheck;Mtonga, George;Agathis, Nickolas;Kayira, Dumbani;Hrapcak, Susan;Patel, Monita;Kress, Howard;Arons, Melissa; Published Date : December 2024 Pages in Document : 1168-1170 (7 pdf pages) Source : The Pediatric Infectious Disease Journal, 2024, v. 43, no. 12 DOI : https://doi.org/10.1097/INF.0000000000004491 Journal Title : The Pediatric Infectious Disease Journal
Chapman, K. S., Luhanga, M., Mtonga, G., Agathis, N., Kayira, D., Hrapcak, S., Patel, M., Kress, H., & Arons, M. (2024). Mortality Among Children Under Five Years of Age Living With HIV on Antiretroviral Treatment From HIV Case Surveillance Data, Malawi, 2022. The Pediatric Infectious Disease Journal, 43(12). https://doi.org/10.1097/INF.0000000000004491

Chapman, Kelly S., Misheck Luhanga, George Mtonga, Nickolas Agathis, Dumbani Kayira, Susan Hrapcak, Monita Patel, Howard Kress, and Melissa Arons. "Mortality Among Children Under Five Years of Age Living With HIV on Antiretroviral Treatment From HIV Case Surveillance Data, Malawi, 2022." The Pediatric Infectious Disease Journal 43, no. 12 (2024). https://doi.org/10.1097/INF.0000000000004491.

Chapman, Kelly S., et al. "Mortality Among Children Under Five Years of Age Living With HIV on Antiretroviral Treatment From HIV Case Surveillance Data, Malawi, 2022." The Pediatric Infectious Disease Journal, vol. 43, no. 12, 2024. Stacks. https://doi.org/10.1097/INF.0000000000004491.
Export RIS Citation Information. TY - Journal Article AU - Chapman, Kelly S. AU - Luhanga, Misheck AU - Mtonga, George AU - Agathis, Nickolas AU - Kayira, Dumbani AU - Hrapcak, Susan AU - Patel, Monita AU - Kress, Howard AU - Arons, Melissa AB - From Malawi's HIV case surveillance, we report clinical characteristics and outcomes of 4461 children living with HIV on antiretroviral treatment <5 years old from January to December, 2022. Among the 4% of children living with HIV who died, 43% were asymptomatic, 35% had advanced or severe symptoms at the time of HIV diagnosis and 50% died within 6 months of receiving an HIV diagnosis. AB - Author manuscript AN - cdc:262063 C4 - PMC11862962 DO - https://doi.org/10.1097/INF.0000000000004491 IS - 12 J2 - The Pediatric Infectious Disease Journal KW - Female KW - Anti-HIV Agents KW - Infant KW - Male KW - Humans KW - Infant, Newborn KW - Child, Preschool KW - Anti-Retroviral Agents KW - HIV Infections KW - HIV KW - mortality KW - Malawi KW - children KW - case surveillance KW - Humans KW - HIV Infections KW - Infant KW - Child, Preschool KW - Male KW - Female KW - Anti-HIV Agents KW - Anti-Retroviral Agents KW - Infant, Newborn LA - eng PY - 2024 T2 - The Pediatric Infectious Disease Journal T2 - The Pediatric Infectious Disease Journal, 2024, v. 43, no. 12 TI - Mortality Among Children Under Five Years of Age Living With HIV on Antiretroviral Treatment From HIV Case Surveillance Data, Malawi, 2022. VL - 43 UR - https://stacks.cdc.gov/view/cdc/262063 ER -
Multiple Metal Exposures Associate With Higher Amyotrophic Lateral Sclerosis Risk and Mortality Independent of Genetic Risk and Correlate to Self-reported Exposures: a Case-control Study.

Jang, Dae Gyu ;

Dou, John

March 2025 | Journal of Neurology, Neurosurgery, and Psychiatry, 2025, v. 96, no. 4

The pathogenesis of amyotrophic lateral sclerosis (ALS) involves both genetic and environmental factors. This study investigates associations between metal measures in plasma and urine, ALS risk and survival and exposure sources.Participants with and without ALS from Michigan provided plasma and urine samples for metal measurement via inductively c ...

10/10/2026

Supporting Files

Title : Multiple Metal Exposures Associate With Higher Amyotrophic Lateral Sclerosis Risk and Mortality Independent of Genetic Risk and Correlate to Self-reported Exposures: a Case-control Study. Personal Author(s) : Jang, Dae Gyu;Dou, John;Koubek, Emily J.;Teener, Samuel;Zhao, Lili;Bakulski, Kelly M.;Mukherjee, Bhramar;Batterman, Stuart A.;Feldman, Eva L.;Goutman, Stephen A.; Published Date : March 2025 Pages in Document : 329-339 (29 pdf pages) Source : Journal of Neurology, Neurosurgery, and Psychiatry, 2025, v. 96, no. 4 DOI : https://doi.org/10.1136/jnnp-2024-333978 Journal Title : Journal of Neurology, Neurosurgery, and Psychiatry
Jang, D. G., Dou, J., Koubek, E. J., Teener, S., Zhao, L., Bakulski, K. M., Mukherjee, B., Batterman, S. A., Feldman, E. L., & Goutman, S. A. (2025). Multiple Metal Exposures Associate With Higher Amyotrophic Lateral Sclerosis Risk and Mortality Independent of Genetic Risk and Correlate to Self-reported Exposures: a Case-control Study. Journal of Neurology, Neurosurgery, and Psychiatry, 96(4). https://doi.org/10.1136/jnnp-2024-333978

Jang, Dae Gyu, John Dou, Emily J. Koubek, Samuel Teener, Lili Zhao, Kelly M. Bakulski, Bhramar Mukherjee, Stuart A. Batterman, Eva L. Feldman, and Stephen A. Goutman. "Multiple Metal Exposures Associate With Higher Amyotrophic Lateral Sclerosis Risk and Mortality Independent of Genetic Risk and Correlate to Self-reported Exposures: a Case-control Study." Journal of Neurology, Neurosurgery, and Psychiatry 96, no. 4 (2025). https://doi.org/10.1136/jnnp-2024-333978.

Jang, Dae Gyu, et al. "Multiple Metal Exposures Associate With Higher Amyotrophic Lateral Sclerosis Risk and Mortality Independent of Genetic Risk and Correlate to Self-reported Exposures: a Case-control Study." Journal of Neurology, Neurosurgery, and Psychiatry, vol. 96, no. 4, 2025. Stacks. https://doi.org/10.1136/jnnp-2024-333978.
Export RIS Citation Information. TY - Journal Article AU - Jang, Dae Gyu AU - Dou, John AU - Koubek, Emily J. AU - Teener, Samuel AU - Zhao, Lili AU - Bakulski, Kelly M. AU - Mukherjee, Bhramar AU - Batterman, Stuart A. AU - Feldman, Eva L. AU - Goutman, Stephen A. AB - The pathogenesis of amyotrophic lateral sclerosis (ALS) involves both genetic and environmental factors. This study investigates associations between metal measures in plasma and urine, ALS risk and survival and exposure sources. AB - Participants with and without ALS from Michigan provided plasma and urine samples for metal measurement via inductively coupled plasma mass spectrometry. ORs and HRs for each metal were computed using risk and survival models. Environmental risk scores (ERS) were created to evaluate the association between exposure mixtures and ALS risk and survival and exposure source. ALS (ALS-PGS) and metal (metal-PGS) polygenic risk scores were constructed from an independent genome-wide association study and relevant literature-selected single-nucleotide polymorphisms. AB - Plasma and urine samples from 454 ALS and 294 control participants were analysed. Elevated levels of individual metals, including copper, selenium and zinc, significantly associated with ALS risk and survival. ERS representing metal mixtures strongly associated with ALS risk (plasma, OR=2.95, CI=2.38-3.62, p<0.001; urine, OR=3.10, CI=2.43-3.97, p<0.001) and poorer ALS survival (plasma, HR=1.37, CI=1.20-1.58, p<0.001; urine, HR=1.44, CI=1.23-1.67, p<0.001). Addition of the ALS-PGS or metal-PGS did not alter the significance of metals with ALS risk and survival. Occupations with high potential of metal exposure associated with elevated ERS. Additionally, occupational and non-occupational metal exposures were associated with measured plasma and urine metals. AB - Metals in plasma and urine associated with increased ALS risk and reduced survival, independent of genetic risk, and correlated with occupational and non-occupational metal exposures. These data underscore the significance of metal exposure in ALS risk and progression. AB - Author manuscript AN - cdc:262062 C4 - PMC12841235 DO - https://doi.org/10.1136/jnnp-2024-333978 IS - 4 J2 - Journal of Neurology, Neurosurgery, and Psychiatry KW - Female KW - Zinc KW - Genetic Predisposition to Disease KW - Aged KW - Self Report KW - Amyotrophic Lateral Sclerosis KW - Selenium KW - Risk Factors KW - Genome-Wide Association Study KW - Case-Control Studies KW - Polymorphism, Single Nucleotide KW - Male KW - Metals KW - Copper KW - Humans KW - Middle Aged KW - Environmental Exposure KW - Adult KW - Amyotrophic lateral sclerosis (ALS) KW - metals KW - polygenic risk score KW - environmental risk score KW - Humans KW - Amyotrophic Lateral Sclerosis KW - Male KW - Female KW - Middle Aged KW - Case-Control Studies KW - Aged KW - Metals KW - Environmental Exposure KW - Copper KW - Polymorphism, Single Nucleotide KW - Risk Factors KW - Genome-Wide Association Study KW - Self Report KW - Adult KW - Selenium KW - Genetic Predisposition to Disease KW - Zinc LA - eng PY - 2025 T2 - Journal of Neurology, Neurosurgery, and Psychiatry T2 - Journal of Neurology, Neurosurgery, and Psychiatry, 2025, v. 96, no. 4 TI - Multiple Metal Exposures Associate With Higher Amyotrophic Lateral Sclerosis Risk and Mortality Independent of Genetic Risk and Correlate to Self-reported Exposures: a Case-control Study. VL - 96 UR - https://stacks.cdc.gov/view/cdc/262062 ER -
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024.

Ma, Kevin C. ;

Surie, Diya

March 2026 | Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2026, v. 82, no. 3

Assessing variant-specific coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) and severity can inform public health risk assessments and decisions about vaccine composition. BA.2.86 and its descendants, including JN.1 (referred to collectively as "JN lineages"), emerged in late 2023 and exhibited substantial divergence from co-circulati ...

10/10/2026

Supporting Files

Title : Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024. Personal Author(s) : Ma, Kevin C.;Surie, Diya;Lauring, Adam S.;Martin, Emily T.;Leis, Aleda M.;Papalambros, Leigh;Gaglani, Manjusha;Columbus, Christie;Gottlieb, Robert L.;Ghamande, Shekhar;Peltan, Ithan D.;Brown, Samuel M.;Ginde, Adit A.;Mohr, Nicholas M.;Gibbs, Kevin W.;Hager, David N.;Saeed, Safa;Prekker, Matthew E.;Gong, Michelle Ng;Mohamed, Amira;Johnson, Nicholas J.;Srinivasan, Vasisht;Steingrub, Jay S.;Khan, Akram;Hough, Catherine L.;Duggal, Abhijit;Wilson, Jennifer G.;Qadir, Nida;Chang, Steven Y.;Mallow, Christopher;Kwon, Jennie H.;Parikh, Bijal;Exline, Matthew C.;Vaughn, Ivana A.;Ramesh, Mayur;Safdar, Basmah;Mosier, Jarrod;Harris, Estelle S.;Shapiro, Nathan I.;Felzer, Jamie;Zhu, Yuwei;Grijalva, Carlos G.;Halasa, Natasha;Chappell, James D.;Womack, Kelsey N.;Rhoads, Jillian P.;Baughman, Adrienne;Swan, Sydney A.;Johnson, Cassandra A.;Rice, Todd W.;Casey, Jonathan D.;Blair, Paul W.;Han, Jin H.;Ellington, Sascha;Lewis, Nathaniel M.;Thornburg, Natalie;Paden, Clinton R.;Atherton, Lydia J.;Self, Wesley H.;Dawood, Fatimah S.;DeCuir, Jennifer; Published Date : March 2026 Pages in Document : e595-e603 (17 pdf pages) Source : Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2026, v. 82, no. 3 DOI : https://doi.org/10.1093/cid/ciae405 Journal Title : Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America
Ma, K. C., Surie, D., Lauring, A. S., Martin, E. T., Leis, A. M., Papalambros, L., Gaglani, M., Columbus, C., Gottlieb, R. L., Ghamande, S., Peltan, I. D., Brown, S. M., Ginde, A. A., Mohr, N. M., Gibbs, K. W., Hager, D. N., Saeed, S., Prekker, M. E., Gong, M. N., ... DeCuir, J. (2026). Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 82(3). https://doi.org/10.1093/cid/ciae405

Ma, Kevin C., Diya Surie, Adam S. Lauring, Emily T. Martin, Aleda M. Leis, Leigh Papalambros, and Manjusha Gaglani, et al.. "Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America 82, no. 3 (2026). https://doi.org/10.1093/cid/ciae405.

Ma, Kevin C., et al. "Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024." Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, vol. 82, no. 3, 2026. Stacks. https://doi.org/10.1093/cid/ciae405.
Export RIS Citation Information. TY - Journal Article AU - Ma, Kevin C. AU - Surie, Diya AU - Lauring, Adam S. AU - Martin, Emily T. AU - Leis, Aleda M. AU - Papalambros, Leigh AU - Gaglani, Manjusha AU - Columbus, Christie AU - Gottlieb, Robert L. AU - Ghamande, Shekhar AU - Peltan, Ithan D. AU - Brown, Samuel M. AU - Ginde, Adit A. AU - Mohr, Nicholas M. AU - Gibbs, Kevin W. AU - Hager, David N. AU - Saeed, Safa AU - Prekker, Matthew E. AU - Gong, Michelle Ng AU - Mohamed, Amira AU - Johnson, Nicholas J. AU - Srinivasan, Vasisht AU - Steingrub, Jay S. AU - Khan, Akram AU - Hough, Catherine L. AU - Duggal, Abhijit AU - Wilson, Jennifer G. AU - Qadir, Nida AU - Chang, Steven Y. AU - Mallow, Christopher AU - Kwon, Jennie H. AU - Parikh, Bijal AU - Exline, Matthew C. AU - Vaughn, Ivana A. AU - Ramesh, Mayur AU - Safdar, Basmah AU - Mosier, Jarrod AU - Harris, Estelle S. AU - Shapiro, Nathan I. AU - Felzer, Jamie AU - Zhu, Yuwei AU - Grijalva, Carlos G. AU - Halasa, Natasha AU - Chappell, James D. AU - Womack, Kelsey N. AU - Rhoads, Jillian P. AU - Baughman, Adrienne AU - Swan, Sydney A. AU - Johnson, Cassandra A. AU - Rice, Todd W. AU - Casey, Jonathan D. AU - Blair, Paul W. AU - Han, Jin H. AU - Ellington, Sascha AU - Lewis, Nathaniel M. AU - Thornburg, Natalie AU - Paden, Clinton R. AU - Atherton, Lydia J. AU - Self, Wesley H. AU - Dawood, Fatimah S. AU - DeCuir, Jennifer AB - Assessing variant-specific coronavirus disease 2019 (COVID-19) vaccine effectiveness (VE) and severity can inform public health risk assessments and decisions about vaccine composition. BA.2.86 and its descendants, including JN.1 (referred to collectively as "JN lineages"), emerged in late 2023 and exhibited substantial divergence from co-circulating XBB lineages. AB - We analyzed patients hospitalized with COVID-19-like illness at 26 hospitals in 20 US states admitted 18 October 2023-9 March 2024. Using a test-negative, case-control design, we estimated effectiveness of an updated 2023-2024 (monovalent XBB.1.5) COVID-19 vaccine dose against sequence-confirmed XBB and JN lineage hospitalization using logistic regression. Odds of severe outcomes, including intensive care unit (ICU) admission and invasive mechanical ventilation (IMV) or death, were compared for JN versus XBB lineage hospitalizations using logistic regression. AB - A total of 585 case-patients with XBB lineages, 397 case-patients with JN lineages, and 4580 control patients were included. VE in the first 7-89 days after receipt of an updated dose was 54.2% (95% confidence interval [CI], 36.1-67.1%) against XBB lineage hospitalization and 32.7% (95% CI, 1.9-53.8%) against JN lineage hospitalization. Odds of ICU admission (adjusted odds ratio [aOR], .80; 95% CI, .46-1.38) and IMV or death (aOR, .69; 95% CI, .34-1.40) were not significantly different among JN compared with XBB lineage hospitalizations. AB - Updated 2023-2024 COVID-19 vaccination provided protection against both XBB and JN lineage hospitalization, but protection against the latter may be attenuated by immune escape. Clinical severity of JN lineage hospitalizations was not higher relative to XBB. AB - Author manuscript AN - cdc:262061 C4 - PMC13193650 DO - https://doi.org/10.1093/cid/ciae405 IS - 3 J2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America KW - Female KW - Vaccination KW - SARS-CoV-2 KW - Aged KW - COVID-19 KW - Severity of Illness Index KW - COVID-19 Vaccines KW - Vaccine Efficacy KW - Hospitalization KW - Case-Control Studies KW - Male KW - Middle Aged KW - Humans KW - Adult KW - SARS-COV-2 variants KW - COVID-19 vaccine effectiveness KW - JN.1 and BA.2.86 KW - test-negative design KW - COVID-19 severity KW - Humans KW - COVID-19 KW - Male KW - SARS-CoV-2 KW - Female KW - Hospitalization KW - Middle Aged KW - Vaccine Efficacy KW - COVID-19 Vaccines KW - Aged KW - Case-Control Studies KW - Adult KW - Severity of Illness Index KW - Vaccination LA - eng PY - 2026 T2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America T2 - Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 2026, v. 82, no. 3 TI - Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, 18 October 2023-9 March 2024. VL - 82 UR - https://stacks.cdc.gov/view/cdc/262061 ER -
Racial Disparities in Maternal Exposure to Ambient Air Pollution During Pregnancy and Prevalence of Congenital Heart Defects.

Arogbokun Knutson, Olufunmilayo C. ;

Luben, Thomas J.

March 2025 | American Journal of Epidemiology, 2025, v. 194, no. 3

Air pollution may be a potential cause of congenital heart defects (CHDs), but racial disparities in this association are unexplored. We conducted a statewide population-based cohort study using North Carolina birth data from 2003 to 2015 (n = 1 225 285) to investigate the relationship between air pollution and CHDs (specifically pulmonary valve at ...

10/10/2026

Supporting Files

Title : Racial Disparities in Maternal Exposure to Ambient Air Pollution During Pregnancy and Prevalence of Congenital Heart Defects. Personal Author(s) : Arogbokun Knutson, Olufunmilayo C.;Luben, Thomas J.;Stingone, Jeanette A.;Engel, Lawrence S.;Martin, Chantel L.;Olshan, Andrew F.; Published Date : March 2025 Pages in Document : 709-721 (26 pdf pages) Source : American Journal of Epidemiology, 2025, v. 194, no. 3 DOI : https://doi.org/10.1093/aje/kwae253 Journal Title : American Journal of Epidemiology
Arogbokun Knutson, O. C., Luben, T. J., Stingone, J. A., Engel, L. S., Martin, C. L., & Olshan, A. F. (2025). Racial Disparities in Maternal Exposure to Ambient Air Pollution During Pregnancy and Prevalence of Congenital Heart Defects. American Journal of Epidemiology, 194(3). https://doi.org/10.1093/aje/kwae253

Arogbokun Knutson, Olufunmilayo C., Thomas J. Luben, Jeanette A. Stingone, Lawrence S. Engel, Chantel L. Martin, and Andrew F. Olshan. "Racial Disparities in Maternal Exposure to Ambient Air Pollution During Pregnancy and Prevalence of Congenital Heart Defects." American Journal of Epidemiology 194, no. 3 (2025). https://doi.org/10.1093/aje/kwae253.

Arogbokun Knutson, Olufunmilayo C., et al. "Racial Disparities in Maternal Exposure to Ambient Air Pollution During Pregnancy and Prevalence of Congenital Heart Defects." American Journal of Epidemiology, vol. 194, no. 3, 2025. Stacks. https://doi.org/10.1093/aje/kwae253.
Export RIS Citation Information. TY - Journal Article AU - Arogbokun Knutson, Olufunmilayo C. AU - Luben, Thomas J. AU - Stingone, Jeanette A. AU - Engel, Lawrence S. AU - Martin, Chantel L. AU - Olshan, Andrew F. AB - Air pollution may be a potential cause of congenital heart defects (CHDs), but racial disparities in this association are unexplored. We conducted a statewide population-based cohort study using North Carolina birth data from 2003 to 2015 (n = 1 225 285) to investigate the relationship between air pollution and CHDs (specifically pulmonary valve atresia/stenosis, tetralogy of Fallot [TOF], and atrioventricular septal defect [AVSD]). Maternal exposure to particulate matter ≤ 2.5 μm in diameter (PM2.5) and ozone during weeks 3 to 9 of pregnancy were estimated using the Environmental Protection Agency's Downscaler Model. Single- and co-pollutant log-binomial models were created for the entire population and stratified by race to investigate disparities. Positive associations between PM2.5 and CHDs were observed. An increasing concentration-response association was found for PM2.5 and TOF in adjusted, co-pollutant models (quartile 4 prevalence ratio: 1.46; 95% CI, 1.06-2.03). Differences in the effect of PM2.5 on CHD prevalence were seen in some models stratified by race, although clear exposure-prevalence gradients were not evident. Positive associations were also seen in adjusted, co-pollutant models of ozone and AVSD. Study results suggest that prenatal PM2.5 and ozone exposure may increase the prevalence of certain CHDs. A consistent pattern of differences in association by race/ethnicity was not apparent. This article is part of a Special Collection on Environmental Epidemiology. AB - Author manuscript AN - cdc:262060 C4 - PMC11955996 DO - https://doi.org/10.1093/aje/kwae253 IS - 3 J2 - American Journal of Epidemiology KW - Pregnancy KW - Female KW - Racial Groups KW - Ozone KW - Health Status Disparities KW - Young Adult KW - Particulate Matter KW - Air Pollution KW - Maternal Exposure KW - Prevalence KW - Heart Defects, Congenital KW - Humans KW - Air Pollutants KW - Adult KW - congenital heart defects KW - air pollution KW - pregnancy KW - racial disparities KW - birth defects KW - Adult KW - Female KW - Humans KW - Pregnancy KW - Young Adult KW - Air Pollutants KW - Air Pollution KW - Health Status Disparities KW - Heart Defects, Congenital KW - Maternal Exposure KW - Ozone KW - Particulate Matter KW - Prevalence KW - Racial Groups LA - eng PY - 2025 T2 - American Journal of Epidemiology T2 - American Journal of Epidemiology, 2025, v. 194, no. 3 TI - Racial Disparities in Maternal Exposure to Ambient Air Pollution During Pregnancy and Prevalence of Congenital Heart Defects. VL - 194 UR - https://stacks.cdc.gov/view/cdc/262060 ER -
The Emergent Invasive Serotype 4 ST10172 Strain Acquires VanG-Type Vancomycin-Resistance Element: a Case of a 66-Year-Old With Bacteremic Pneumococcal Pneumonia.

Chochua, Sopio ;

Beall, Bernard

March 2025 | The Journal of Infectious Diseases, 2025, v. 231, no. 3

We report a single case of invasive pneumococcal disease (IPD) by serotype 4, multilocus sequence type 10172 (ST10172) isolate with vanG-type resistance genes and reduced vancomycin susceptibility. The isolate was recovered during 2022 from a 66-year-old resident with bacteremic pneumococcal pneumonia within a Centers for Disease Control and Preven ...

10/10/2026

Supporting Files

Title : The Emergent Invasive Serotype 4 ST10172 Strain Acquires VanG-Type Vancomycin-Resistance Element: a Case of a 66-Year-Old With Bacteremic Pneumococcal Pneumonia. Personal Author(s) : Chochua, Sopio;Beall, Bernard;Lin, Wuling;Tran, Theresa;Rivers, Joy;Li, Zhongya;Arvay, Melissa L.;Kobayashi, Miwako;Houston, Jessica;Arias, Sabra;McGee, Lesley; Published Date : March 2025 Pages in Document : 746-750 (9 pdf pages) Source : The Journal of Infectious Diseases, 2025, v. 231, no. 3 DOI : https://doi.org/10.1093/infdis/jiae393 Journal Title : The Journal of Infectious Diseases
Chochua, S., Beall, B., Lin, W., Tran, T., Rivers, J., Li, Z., Arvay, M. L., Kobayashi, M., Houston, J., Arias, S., & McGee, L. (2025). The Emergent Invasive Serotype 4 ST10172 Strain Acquires VanG-Type Vancomycin-Resistance Element: a Case of a 66-Year-Old With Bacteremic Pneumococcal Pneumonia. The Journal of Infectious Diseases, 231(3). https://doi.org/10.1093/infdis/jiae393

Chochua, Sopio, Bernard Beall, Wuling Lin, Theresa Tran, Joy Rivers, Zhongya Li, and Melissa L. Arvay, et al.. "The Emergent Invasive Serotype 4 ST10172 Strain Acquires VanG-Type Vancomycin-Resistance Element: a Case of a 66-Year-Old With Bacteremic Pneumococcal Pneumonia." The Journal of Infectious Diseases 231, no. 3 (2025). https://doi.org/10.1093/infdis/jiae393.

Chochua, Sopio, et al. "The Emergent Invasive Serotype 4 ST10172 Strain Acquires VanG-Type Vancomycin-Resistance Element: a Case of a 66-Year-Old With Bacteremic Pneumococcal Pneumonia." The Journal of Infectious Diseases, vol. 231, no. 3, 2025. Stacks. https://doi.org/10.1093/infdis/jiae393.
Export RIS Citation Information. TY - Journal Article AU - Chochua, Sopio AU - Beall, Bernard AU - Lin, Wuling AU - Tran, Theresa AU - Rivers, Joy AU - Li, Zhongya AU - Arvay, Melissa L. AU - Kobayashi, Miwako AU - Houston, Jessica AU - Arias, Sabra AU - McGee, Lesley AB - We report a single case of invasive pneumococcal disease (IPD) by serotype 4, multilocus sequence type 10172 (ST10172) isolate with vanG-type resistance genes and reduced vancomycin susceptibility. The isolate was recovered during 2022 from a 66-year-old resident with bacteremic pneumococcal pneumonia within a Centers for Disease Control and Prevention Active Bacterial Core surveillance (ABCs) site hospital. The patient had received 23-valent pneumococcal polysaccharide vaccine and there was no evidence of concurrent or prior receipt of vancomycin in the previous year. Serotype 4/ST10172 IPD has shown increases within western ABCs sites, and the recent acquisition of a vanG element warrants close monitoring of this lineage. AB - Author manuscript AN - cdc:262059 C4 - PMC13067368 DO - https://doi.org/10.1093/infdis/jiae393 IS - 3 J2 - The Journal of Infectious Diseases KW - Bacteremia KW - Bacterial Proteins KW - Streptococcus pneumoniae KW - Aged KW - Pneumococcal Vaccines KW - Serogroup KW - Pneumonia, Pneumococcal KW - Multilocus Sequence Typing KW - Vancomycin KW - Humans KW - Anti-Bacterial Agents KW - Microbial Sensitivity Tests KW - Vancomycin Resistance KW - Streptococcus pneumoniae KW - invasive pneumococcal disease KW - antibiotics KW - vancomycin resistance KW - emergent lineages KW - Aged KW - Humans KW - Anti-Bacterial Agents KW - Bacteremia KW - Bacterial Proteins KW - Microbial Sensitivity Tests KW - Multilocus Sequence Typing KW - Pneumococcal Vaccines KW - Pneumonia, Pneumococcal KW - Serogroup KW - Streptococcus pneumoniae KW - Vancomycin KW - Vancomycin Resistance LA - eng PY - 2025 T2 - The Journal of Infectious Diseases T2 - The Journal of Infectious Diseases, 2025, v. 231, no. 3 TI - The Emergent Invasive Serotype 4 ST10172 Strain Acquires VanG-Type Vancomycin-Resistance Element: a Case of a 66-Year-Old With Bacteremic Pneumococcal Pneumonia. VL - 231 UR - https://stacks.cdc.gov/view/cdc/262059 ER -
Equipping the Public Health Workforce of the Future: Evaluation of An Evidence-Based Public Health Training Delivered Through Academic-Health Department Partnerships.

Mazzucca-Ragan, Stephanie ;

Brownson, Carol A.

March 20, 2025 | Journal of Public Health Management and Practice: JPHMP, 2025, v. 31, no. 1

Maintaining a skilled public health workforce is essential but challenging given high turnover and that few staff hold a public health degree. Situating workforce development within existing structures leverages the strengths of different organizations and can build relationships to address public health challenges and health equity. We implemented ...

10/10/2026

Supporting Files

Title : Equipping the Public Health Workforce of the Future: Evaluation of An Evidence-Based Public Health Training Delivered Through Academic-Health Department Partnerships. Personal Author(s) : Mazzucca-Ragan, Stephanie;Brownson, Carol A.;Crouch, Maurine M.;Davis, Sarah;Duffany, Kathleen O.;Erwin, Paul C.;Leiferman, Jenn A.;McCormick, Lisa C.;Walker, Jeffery T.;Brownson, Ross C.; Published Date : March 20, 2025 Pages in Document : 51-60 (17 pdf pages) Source : Journal of Public Health Management and Practice: JPHMP, 2025, v. 31, no. 1 DOI : https://doi.org/10.1097/PHH.0000000000001985 Journal Title : Journal of Public Health Management and Practice: JPHMP
Mazzucca-Ragan, S., Brownson, C. A., Crouch, M. M., Davis, S., Duffany, K. O., Erwin, P. C., Leiferman, J. A., McCormick, L. C., Walker, J. T., & Brownson, R. C. (2025). Equipping the Public Health Workforce of the Future: Evaluation of An Evidence-Based Public Health Training Delivered Through Academic-Health Department Partnerships. Journal of Public Health Management and Practice: JPHMP, 31(1). https://doi.org/10.1097/PHH.0000000000001985

Mazzucca-Ragan, Stephanie, Carol A. Brownson, Maurine M. Crouch, Sarah Davis, Kathleen O. Duffany, Paul C. Erwin, Jenn A. Leiferman, Lisa C. McCormick, Jeffery T. Walker, and Ross C. Brownson. "Equipping the Public Health Workforce of the Future: Evaluation of An Evidence-Based Public Health Training Delivered Through Academic-Health Department Partnerships." Journal of Public Health Management and Practice: JPHMP 31, no. 1 (2025). https://doi.org/10.1097/PHH.0000000000001985.

Mazzucca-Ragan, Stephanie, et al. "Equipping the Public Health Workforce of the Future: Evaluation of An Evidence-Based Public Health Training Delivered Through Academic-Health Department Partnerships." Journal of Public Health Management and Practice: JPHMP, vol. 31, no. 1, 2025. Stacks. https://doi.org/10.1097/PHH.0000000000001985.
Export RIS Citation Information. TY - Journal Article AU - Mazzucca-Ragan, Stephanie AU - Brownson, Carol A. AU - Crouch, Maurine M. AU - Davis, Sarah AU - Duffany, Kathleen O. AU - Erwin, Paul C. AU - Leiferman, Jenn A. AU - McCormick, Lisa C. AU - Walker, Jeffery T. AU - Brownson, Ross C. AB - Maintaining a skilled public health workforce is essential but challenging given high turnover and that few staff hold a public health degree. Situating workforce development within existing structures leverages the strengths of different organizations and can build relationships to address public health challenges and health equity. We implemented and evaluated an innovative, sustainable model to deliver an established evidence-based public health (EBPH) training collaboratively among Prevention Research Centers (PRC), local and state health departments, and Public Health Training Centers (PHTC). AB - Quantitative data: quasi-experimental, 1-group pre-post. Qualitative data: cross-sectional. Data were collected between December 2021 and August 2022. AB - Four US sites, each a partnership between a PRC, local or state health department, and a PHTC. AB - Governmental public health staff and representatives from other organizations that implement public health programs in practice settings. AB - Course participants completed a pre- and postcourse survey self-rating 14 skills on a 5-point Likert scale. Differences were analyzed using mixed effects linear models. In-depth interviews (n = 15) were conducted with course faculty and partners to understand: (1) resources contributed, (2) barriers and facilitators, (3) benefits and challenges, and (4) resources needed to sustain this model. Interviews were transcribed verbatim, and a thematic analysis identified themes. AB - Statistically significant increases in all skills were observed from pre- to postcourse (n = 241 at post, 90% response). The skills with the largest increases were understanding economic evaluation enough to inform decision-making (mean change = 1.22, standard error [SE] = 0.05) and developing an action plan (mean change = 1.07, SE = 0.07). Facilitators to delivering the course included having a shared goal of workforce development, existing course curricula, and dedicated funding for delivering the course. AB - Collaborative delivery of the EBPH training can ameliorate the effects of high staff turnover, strengthen academic-practice relationships, and promote population-wide health and health equity. AB - Author manuscript AN - cdc:262058 C4 - PMC11925482 DO - https://doi.org/10.1097/PHH.0000000000001985 IS - 1 J2 - Journal of Public Health Management and Practice: JPHMP KW - Workforce KW - Cross-Sectional Studies KW - Surveys and Questionnaires KW - Qualitative Research KW - Public Health KW - Humans KW - Evidence-Based Practice KW - Health Workforce KW - capacity building KW - chronic Disease KW - population health KW - public health education KW - public health practice KW - scale-up KW - Humans KW - Public Health KW - Cross-Sectional Studies KW - Surveys and Questionnaires KW - Qualitative Research KW - Evidence-Based Practice KW - Workforce KW - Health Workforce LA - eng PY - 2025 T2 - Journal of Public Health Management and Practice: JPHMP T2 - Journal of Public Health Management and Practice: JPHMP, 2025, v. 31, no. 1 TI - Equipping the Public Health Workforce of the Future: Evaluation of An Evidence-Based Public Health Training Delivered Through Academic-Health Department Partnerships. VL - 31 UR - https://stacks.cdc.gov/view/cdc/262058 ER -
Adverse Childhood Experiences Module Nonresponse: Behavioral Risk Factor Surveillance System, 2019 and 2021.

Besera, Ghenet ;

Annor, Francis B.

December 2024 | American Journal of Preventive Medicine, 2024, v. 67, no. 6

Data on adverse childhood experiences are key to understanding their burden and informing prevention programs and strategies. Population-based surveys that collect adverse childhood experiences data may be affected by item nonresponse. This study examines differences in nonresponse to the optional Behavioral Risk Factor Surveillance System adverse ...

10/10/2026

Supporting Files

Title : Adverse Childhood Experiences Module Nonresponse: Behavioral Risk Factor Surveillance System, 2019 and 2021. Personal Author(s) : Besera, Ghenet;Annor, Francis B.;Swedo, Elizabeth A.;Aslam, Maria V.;Massetti, Greta M.; Published Date : December 2024 Pages in Document : 941-950 (16 pdf pages) Source : American Journal of Preventive Medicine, 2024, v. 67, no. 6 DOI : https://doi.org/10.1016/j.amepre.2024.08.001 Journal Title : American Journal of Preventive Medicine
Besera, G., Annor, F. B., Swedo, E. A., Aslam, M. V., & Massetti, G. M. (2024). Adverse Childhood Experiences Module Nonresponse: Behavioral Risk Factor Surveillance System, 2019 and 2021. American Journal of Preventive Medicine, 67(6). https://doi.org/10.1016/j.amepre.2024.08.001

Besera, Ghenet, Francis B. Annor, Elizabeth A. Swedo, Maria V. Aslam, and Greta M. Massetti. "Adverse Childhood Experiences Module Nonresponse: Behavioral Risk Factor Surveillance System, 2019 and 2021." American Journal of Preventive Medicine 67, no. 6 (2024). https://doi.org/10.1016/j.amepre.2024.08.001.

Besera, Ghenet, et al. "Adverse Childhood Experiences Module Nonresponse: Behavioral Risk Factor Surveillance System, 2019 and 2021." American Journal of Preventive Medicine, vol. 67, no. 6, 2024. Stacks. https://doi.org/10.1016/j.amepre.2024.08.001.
Export RIS Citation Information. TY - Journal Article AU - Besera, Ghenet AU - Annor, Francis B. AU - Swedo, Elizabeth A. AU - Aslam, Maria V. AU - Massetti, Greta M. AB - Data on adverse childhood experiences are key to understanding their burden and informing prevention programs and strategies. Population-based surveys that collect adverse childhood experiences data may be affected by item nonresponse. This study examines differences in nonresponse to the optional Behavioral Risk Factor Surveillance System adverse childhood experiences module overall, by sociodemographic characteristics, by year, and by question. AB - This study used Behavioral Risk Factor Surveillance System adverse childhood experiences module data from 21 states in 2019 and 16 states in 2021. Weighted proportions and 95% CIs of responders and nonresponders to the adverse childhood experiences module by year and sociodemographic characteristics and percentages of nonresponders for each question were calculated. Chi-square tests were used to assess statistically significant (p<0.05) differences. Analyses were conducted in 2023. AB - In 2019 and 2021, 1.2% (95% CI=1.1, 1.4) and 2.4% (95% CI=2.2, 2.5) of Behavioral Risk Factor Surveillance System participants were nonresponders to the adverse childhood experiences module, respectively (p<0.01). Nonresponders were more likely to be non-Hispanic Black (p=0.01) or non-Hispanic Asian (p=0.01), to be unemployed (p<0.01), to have income <$15,000 (p<0.01), or to report poor health (p<0.01) than responders. Nonresponse by question increased as the module progressed, and nonresponse was highest for sexual abuse questions. AB - Overall, findings demonstrate that individuals are willing to respond to the adverse childhood experiences module questions. Although low, nonresponse to the module increased from 2019 to 2021. Higher nonresponse for sexual abuse questions may be due to their sensitivity or potential survey fatigue due to placement at the end of the module. Higher nonresponse among racial/ethnic minorities and economically disadvantages groups highlights opportunities to improve existing surveillance systems. AB - Author manuscript AN - cdc:262057 C4 - PMC11752077 DO - https://doi.org/10.1016/j.amepre.2024.08.001 IS - 6 J2 - American Journal of Preventive Medicine KW - Adolescent KW - Child KW - Adverse Childhood Experiences KW - Surveys and Questionnaires KW - Female KW - Behavioral Risk Factor Surveillance System KW - Male KW - Humans KW - Middle Aged KW - Young Adult KW - Sociodemographic Factors KW - Adult KW - Humans KW - Behavioral Risk Factor Surveillance System KW - Male KW - Female KW - Adverse Childhood Experiences KW - Adult KW - Adolescent KW - Middle Aged KW - Young Adult KW - Surveys and Questionnaires KW - Sociodemographic Factors KW - Child LA - eng PY - 2024 T2 - American Journal of Preventive Medicine T2 - American Journal of Preventive Medicine, 2024, v. 67, no. 6 TI - Adverse Childhood Experiences Module Nonresponse: Behavioral Risk Factor Surveillance System, 2019 and 2021. VL - 67 UR - https://stacks.cdc.gov/view/cdc/262057 ER -
Vaccine Effectiveness Against Anal HPV Among Men Who Have Sex With Men Aged 18-45 Years Attending Sexual Health Clinics in 3 United States Cities, 2018-2023.

DeSisto, Carla L. ;

Winer, Rachel L.

March 2025 | The Journal of Infectious Diseases, 2025, v. 231, no. 3

We assessed human papillomavirus (HPV) vaccine effectiveness (VE) against anal HPV among men who have sex with men (MSM) in 2018-2023.Residual anal specimens from MSM without HIV aged 18-45 years were tested for HPV. We calculated adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) for associations between vaccination (≥1 dose) and q ...

10/10/2026

Supporting Files

Title : Vaccine Effectiveness Against Anal HPV Among Men Who Have Sex With Men Aged 18-45 Years Attending Sexual Health Clinics in 3 United States Cities, 2018-2023. Personal Author(s) : DeSisto, Carla L.;Winer, Rachel L.;Querec, Troy D.;Dada, Damilola;Pathela, Preeti;Asbel, Lenore;Lin, John;Tang, Jennifer;Iqbal, Alfred;Meites, Elissa;Unger, Elizabeth R.;Markowitz, Lauri E.; Published Date : March 2025 Pages in Document : 751-761 (21 pdf pages) Source : The Journal of Infectious Diseases, 2025, v. 231, no. 3 DOI : https://doi.org/10.1093/infdis/jiae394 Journal Title : The Journal of Infectious Diseases
DeSisto, C. L., Winer, R. L., Querec, T. D., Dada, D., Pathela, P., Asbel, L., Lin, J., Tang, J., Iqbal, A., Meites, E., Unger, E. R., & Markowitz, L. E. (2025). Vaccine Effectiveness Against Anal HPV Among Men Who Have Sex With Men Aged 18-45 Years Attending Sexual Health Clinics in 3 United States Cities, 2018-2023. The Journal of Infectious Diseases, 231(3). https://doi.org/10.1093/infdis/jiae394

DeSisto, Carla L., Rachel L. Winer, Troy D. Querec, Damilola Dada, Preeti Pathela, Lenore Asbel, and John Lin, et al.. "Vaccine Effectiveness Against Anal HPV Among Men Who Have Sex With Men Aged 18-45 Years Attending Sexual Health Clinics in 3 United States Cities, 2018-2023." The Journal of Infectious Diseases 231, no. 3 (2025). https://doi.org/10.1093/infdis/jiae394.

DeSisto, Carla L., et al. "Vaccine Effectiveness Against Anal HPV Among Men Who Have Sex With Men Aged 18-45 Years Attending Sexual Health Clinics in 3 United States Cities, 2018-2023." The Journal of Infectious Diseases, vol. 231, no. 3, 2025. Stacks. https://doi.org/10.1093/infdis/jiae394.
Export RIS Citation Information. TY - Journal Article AU - DeSisto, Carla L. AU - Winer, Rachel L. AU - Querec, Troy D. AU - Dada, Damilola AU - Pathela, Preeti AU - Asbel, Lenore AU - Lin, John AU - Tang, Jennifer AU - Iqbal, Alfred AU - Meites, Elissa AU - Unger, Elizabeth R. AU - Markowitz, Lauri E. AB - We assessed human papillomavirus (HPV) vaccine effectiveness (VE) against anal HPV among men who have sex with men (MSM) in 2018-2023. AB - Residual anal specimens from MSM without HIV aged 18-45 years were tested for HPV. We calculated adjusted prevalence ratios (aPR) and 95% confidence intervals (CI) for associations between vaccination (≥1 dose) and quadrivalent vaccine (4vHPV)-type prevalence adjusting for city, race/ethnicity, and nonvaccine-type HPV prevalence, stratified by age group (18-26, 27-45 years). VE was calculated as (1 - aPR) × 100. AB - Among 2802 persons aged 18-26, 4vHPV-type prevalence was lower in those vaccinated at age <18 (aPR = 0.13; 95% CI, .08-.22; VE = 87%) and those vaccinated ≥2 years before specimen collection (aPR = 0.52; 95% CI, .42-.64; VE = 48%) compared with unvaccinated persons. Among 3548 persons aged 27-45, 4vHPV-type prevalence was lower in those vaccinated at ages 18-26 (aPR = 0.68; 95% CI, .57-.82; VE = 32%) and those vaccinated ≥2 years before specimen collection (aPR = 0.66; 95% CI, .57-.77; VE = 33%) compared with unvaccinated persons. While we observed no VE in persons vaccinated at age >26 overall, 4vHPV-type prevalence was lower in the subgroup vaccinated ≥2 years before specimen collection (aPR = 0.71; 95% CI, .56-.89; VE = 29%). AB - We found high VE against anal 4vHPV-type prevalence among MSM aged 18-26 who were vaccinated at age <18. Lower VE was observed among MSM aged 27-45 who were vaccinated at age 18-26 or ≥2 years before specimen collection. While ideally vaccination should be given at younger ages, vaccination can prevent some future infections in this population. AB - Author manuscript AN - cdc:262056 C4 - PMC11878371 DO - https://doi.org/10.1093/infdis/jiae394 IS - 3 J2 - The Journal of Infectious Diseases KW - Anal Canal KW - Adolescent KW - Vaccination KW - Papillomavirus Vaccines KW - Young Adult KW - Homosexuality, Male KW - Papillomaviridae KW - Papillomavirus Infections KW - Vaccine Efficacy KW - Prevalence KW - Male KW - Humans KW - Middle Aged KW - Adult KW - papillomavirus vaccines KW - papillomavirus infections KW - sexual and gender minorities KW - vaccination KW - Humans KW - Male KW - Adult KW - Papillomavirus Infections KW - Young Adult KW - Adolescent KW - Middle Aged KW - Homosexuality, Male KW - Papillomavirus Vaccines KW - Anal Canal KW - Prevalence KW - Vaccine Efficacy KW - Vaccination KW - Papillomaviridae LA - eng PY - 2025 T2 - The Journal of Infectious Diseases T2 - The Journal of Infectious Diseases, 2025, v. 231, no. 3 TI - Vaccine Effectiveness Against Anal HPV Among Men Who Have Sex With Men Aged 18-45 Years Attending Sexual Health Clinics in 3 United States Cities, 2018-2023. VL - 231 UR - https://stacks.cdc.gov/view/cdc/262056 ER -
Validating ICD-10-CM Diagnostic Codes With Laboratory Test Results For Use in Identifying Chlamydial and Gonococcal Infections Among American Indians and Alaska Natives: Indian Health Service, 2016-2021.

Haberling, Dana L. ;

Mauk, Kerry

December 2024 | Sexually Transmitted Diseases, 2024, v. 51, no. 12

National case rates of chlamydia and gonorrhea (CT/GC) among American Indian and Alaska Native (AI/AN) persons are disproportionately high. The Indian Health Service (IHS), which provides health care to members of federally recognized tribes, does not currently have a dedicated CT/GC surveillance system. The purpose of this study was to validate th ...

10/10/2026

Supporting Files

Title : Validating ICD-10-CM Diagnostic Codes With Laboratory Test Results For Use in Identifying Chlamydial and Gonococcal Infections Among American Indians and Alaska Natives: Indian Health Service, 2016-2021. Personal Author(s) : Haberling, Dana L.;Mauk, Kerry;Bornstein, Ethan;Nuorti, J. Pekka;Apostolou, Andria; Published Date : December 2024 Pages in Document : 794-802 (16 pdf pages) Source : Sexually Transmitted Diseases, 2024, v. 51, no. 12 DOI : https://doi.org/10.1097/OLQ.0000000000002064 Journal Title : Sexually Transmitted Diseases
Haberling, D. L., Mauk, K., Bornstein, E., Nuorti, J. P., & Apostolou, A. (2024). Validating ICD-10-CM Diagnostic Codes With Laboratory Test Results For Use in Identifying Chlamydial and Gonococcal Infections Among American Indians and Alaska Natives: Indian Health Service, 2016-2021. Sexually Transmitted Diseases, 51(12). https://doi.org/10.1097/OLQ.0000000000002064

Haberling, Dana L., Kerry Mauk, Ethan Bornstein, J. Pekka Nuorti, and Andria Apostolou. "Validating ICD-10-CM Diagnostic Codes With Laboratory Test Results For Use in Identifying Chlamydial and Gonococcal Infections Among American Indians and Alaska Natives: Indian Health Service, 2016-2021." Sexually Transmitted Diseases 51, no. 12 (2024). https://doi.org/10.1097/OLQ.0000000000002064.

Haberling, Dana L., et al. "Validating ICD-10-CM Diagnostic Codes With Laboratory Test Results For Use in Identifying Chlamydial and Gonococcal Infections Among American Indians and Alaska Natives: Indian Health Service, 2016-2021." Sexually Transmitted Diseases, vol. 51, no. 12, 2024. Stacks. https://doi.org/10.1097/OLQ.0000000000002064.
Export RIS Citation Information. TY - Journal Article AU - Haberling, Dana L. AU - Mauk, Kerry AU - Bornstein, Ethan AU - Nuorti, J. Pekka AU - Apostolou, Andria AB - National case rates of chlamydia and gonorrhea (CT/GC) among American Indian and Alaska Native (AI/AN) persons are disproportionately high. The Indian Health Service (IHS), which provides health care to members of federally recognized tribes, does not currently have a dedicated CT/GC surveillance system. The purpose of this study was to validate the use of CT/GC diagnostic codes for estimating diagnosed CT/GC infections among AI/AN persons who use IHS services. AB - We conducted a retrospective study using IHS medical records from all persons 15 years and older from 2016 to 2021. We linked records with CT (A56, A74) and GC (A54, O98.2) International Classification of Diseases, 10th Revision, Clinical Modification diagnostic codes to laboratory results within 30 days for each person. We calculated the sensitivity, specificity, and positive and negative predictive values of CT/GC diagnostic codes using laboratory test results as the reference standard. AB - We identified more than 1.6 million CT/GC laboratory tests, and 52,815 CT and 19,971 GC diagnostic codes. Diagnostic code sensitivity was slightly higher for CT (54%) than GC (50%). Specificity, positive predictive value, and negative predictive value were high for CT and GC (range, 83.3%-99.8%). About one-third of CT/GC diagnostic codes could not be linked to a test result. AB - The validation indicates that diagnostic codes align well with linked laboratory test results. However, because of the relatively large number of diagnostic codes and positive test results that could not be linked, combining the 2 would inform more reliable estimates of diagnosed CT/GC infections among AI/AN persons who use IHS for health care. AB - Author manuscript AN - cdc:262055 C4 - PMC11924037 DO - https://doi.org/10.1097/OLQ.0000000000002064 IS - 12 J2 - Sexually Transmitted Diseases KW - International Classification of Diseases KW - Adolescent KW - Female KW - Gonorrhea KW - Sensitivity and Specificity KW - Chlamydia Infections KW - Young Adult KW - American Indian or Alaska Native KW - Retrospective Studies KW - United States Indian Health Service KW - Male KW - Middle Aged KW - Humans KW - Adult KW - chlamydia KW - gonorrhea KW - American Indian and Alaska Native KW - sensitivity KW - ICD-10-CM KW - Adolescent KW - Adult KW - Female KW - Humans KW - Male KW - Middle Aged KW - Young Adult KW - Chlamydia Infections KW - Gonorrhea KW - International Classification of Diseases KW - Retrospective Studies KW - Sensitivity and Specificity KW - United States Indian Health Service KW - American Indian or Alaska Native LA - eng PY - 2024 T2 - Sexually Transmitted Diseases T2 - Sexually Transmitted Diseases, 2024, v. 51, no. 12 TI - Validating ICD-10-CM Diagnostic Codes With Laboratory Test Results For Use in Identifying Chlamydial and Gonococcal Infections Among American Indians and Alaska Natives: Indian Health Service, 2016-2021. VL - 51 UR - https://stacks.cdc.gov/view/cdc/262055 ER -
Engaging Community Health Workers in the Centers For Disease Control and Prevention's COVID-19 Public Health Response to Address Health Disparities and Build Community Resilience.

De Jesus, Stacy ;

Rohan, Elizabeth A.

November 2025 | Health Promotion Practice, 2025, v. 26, no. 6

In 2021, the Centers for Disease Control and Prevention's (CDC) National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) funded community health workers (CHWs) for COVID Response and Resilient Communities (CCR). CCR is a 3-year, $350 million initiative to implement CHW strategies aimed at reducing COVID-19 impacts, building res ...

10/10/2026

Supporting Files

Title : Engaging Community Health Workers in the Centers For Disease Control and Prevention's COVID-19 Public Health Response to Address Health Disparities and Build Community Resilience. Personal Author(s) : De Jesus, Stacy;Rohan, Elizabeth A.;DeGroff, Amy;Vaughan, Marla;Hayes, Nikki;Presley-Cantrell, Letitia;Buckley, Rebekah;Richardson, Lisa C.;Crawford, Gregory;Hacker, Karen; Published Date : November 2025 Pages in Document : 1040-1042 (5 pdf pages) Source : Health Promotion Practice, 2025, v. 26, no. 6 DOI : https://doi.org/10.1177/15248399241267969 Journal Title : Health Promotion Practice
De Jesus, S., Rohan, E. A., DeGroff, A., Vaughan, M., Hayes, N., Presley-Cantrell, L., Buckley, R., Richardson, L. C., Crawford, G., & Hacker, K. (2025). Engaging Community Health Workers in the Centers For Disease Control and Prevention's COVID-19 Public Health Response to Address Health Disparities and Build Community Resilience. Health Promotion Practice, 26(6). https://doi.org/10.1177/15248399241267969

De Jesus, Stacy, Elizabeth A. Rohan, Amy DeGroff, Marla Vaughan, Nikki Hayes, Letitia Presley-Cantrell, Rebekah Buckley, Lisa C. Richardson, Gregory Crawford, and Karen Hacker. "Engaging Community Health Workers in the Centers For Disease Control and Prevention's COVID-19 Public Health Response to Address Health Disparities and Build Community Resilience." Health Promotion Practice 26, no. 6 (2025). https://doi.org/10.1177/15248399241267969.

De Jesus, Stacy, et al. "Engaging Community Health Workers in the Centers For Disease Control and Prevention's COVID-19 Public Health Response to Address Health Disparities and Build Community Resilience." Health Promotion Practice, vol. 26, no. 6, 2025. Stacks. https://doi.org/10.1177/15248399241267969.
Export RIS Citation Information. TY - Journal Article AU - De Jesus, Stacy AU - Rohan, Elizabeth A. AU - DeGroff, Amy AU - Vaughan, Marla AU - Hayes, Nikki AU - Presley-Cantrell, Letitia AU - Buckley, Rebekah AU - Richardson, Lisa C. AU - Crawford, Gregory AU - Hacker, Karen AB - In 2021, the Centers for Disease Control and Prevention's (CDC) National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP) funded community health workers (CHWs) for COVID Response and Resilient Communities (CCR). CCR is a 3-year, $350 million initiative to implement CHW strategies aimed at reducing COVID-19 impacts, building resilience, and improving health equity by addressing health-related social needs. This paper describes the CCR initiative and experiences to date, underscoring CHWs' critical role in CDC's pandemic response. CCR funds 67 recipients to reach communities who are disproportionately affected by long-standing health disparities (hereafter, priority populations). CCR aims to decrease the impact of COVID-19 and increase community resilience to respond to COVID-19 and future public health emergencies. Recipients implement three strategies: train CHWs to support the COVID-19 response, increase the workforce of CHWs to manage the spread of the disease, and improve utilization of community and clinical resources to engage CHWs to help strengthen communities' resilience to mitigate the impact of COVID-19. We funded three additional organizations to provide technical assistance to CCR recipients and collaborate with us on a national evaluation of the program. CCR recipients hired about 950 CHWs and integrated these CHWs into over 1,000 organizations and care teams. At the end of the second program year, CHWs made over 250,000 referrals to social services and over 150,000 referrals to address specific health conditions. CCR demonstrates that CHWs can be quickly mobilized to participate in a public health emergency and reach those most affected by COVID-19. AB - Author manuscript AN - cdc:262054 C4 - PMC11811198 DO - https://doi.org/10.1177/15248399241267969 IS - 6 J2 - Health Promotion Practice KW - Community Health Workers KW - SARS-CoV-2 KW - Public Health KW - Health Status Disparities KW - Humans KW - COVID-19 KW - Health Promotion KW - Centers for Disease Control and Prevention, U.S. KW - CHWs KW - health equity KW - SDOH KW - resilience KW - COVID-19 KW - public health practice KW - communities KW - community engagement KW - Humans KW - COVID-19 KW - Community Health Workers KW - Centers for Disease Control and Prevention, U.S. KW - SARS-CoV-2 KW - Health Status Disparities KW - Health Promotion KW - Public Health LA - eng PY - 2025 T2 - Health Promotion Practice T2 - Health Promotion Practice, 2025, v. 26, no. 6 TI - Engaging Community Health Workers in the Centers For Disease Control and Prevention's COVID-19 Public Health Response to Address Health Disparities and Build Community Resilience. VL - 26 UR - https://stacks.cdc.gov/view/cdc/262054 ER -
The Panzootic Spread of Highly Pathogenic Avian Influenza H5N1 Sublineage 2.3.4.4b: a Critical Appraisal of One Health Preparedness and Prevention.

Koopmans, Marion P G ;

Behravesh, Casey Barton

December 2024 | The Lancet. Infectious Diseases, 2024, v. 24, no. 12

Changes in the epidemiology and ecology of H5N1 highly pathogenic avian influenza are devastating wild bird and poultry populations, farms and communities, and wild mammals worldwide. Having originated in farmed poultry, H5N1 viruses are now spread globally by wild birds, with transmission to many mammal and avian species, resulting in 2024 in tran ...

10/10/2026

Supporting Files

Title : The Panzootic Spread of Highly Pathogenic Avian Influenza H5N1 Sublineage 2.3.4.4b: a Critical Appraisal of One Health Preparedness and Prevention. Personal Author(s) : Koopmans, Marion P G;Behravesh, Casey Barton;Cunningham, Andrew A;Adisasmito, Wiku B;Almuhairi, Salama;Bilivogui, Pépé;Bukachi, Salome A;Casas, Natalia;Becerra, Natalia Cediel;Charron, Dominique F;Chaudhary, Abhishek;Zanella, Janice R Ciacci;Dar, Osman;Debnath, Nitish;Dungu, Baptiste;Farag, Elmoubasher;Gao, George F;Khaitsa, Margaret;Machalaba, Catherine;Mackenzie, John S;Markotter, Wanda;Mettenleiter, Thomas C;Morand, Serge;Smolenskiy, Vyacheslav;Zhou, Lei;Hayman, David T S; Published Date : December 2024 Pages in Document : e774-e781 (14 pdf pages) Source : The Lancet. Infectious Diseases, 2024, v. 24, no. 12 DOI : https://doi.org/10.1016/S1473-3099(24)00438-9 Journal Title : The Lancet. Infectious Diseases
Koopmans, M. P. G., Behravesh, C. B., Cunningham, A. A., Adisasmito, W. B., Almuhairi, S., Bilivogui, P., Bukachi, S. A., Casas, N., Becerra, N. C., Charron, D. F., Chaudhary, A., Zanella, J. R. C., Dar, O., Debnath, N., Dungu, B., Farag, E., Gao, G. F., Khaitsa, M., Machalaba, C., ... Hayman, D. T. S. (2024). The Panzootic Spread of Highly Pathogenic Avian Influenza H5N1 Sublineage 2.3.4.4b: a Critical Appraisal of One Health Preparedness and Prevention. The Lancet. Infectious Diseases, 24(12). https://doi.org/10.1016/S1473-3099(24)00438-9

Koopmans, Marion P G, Casey Barton Behravesh, Andrew A Cunningham, Wiku B Adisasmito, Salama Almuhairi, Pépé Bilivogui, and Salome A Bukachi, et al.. "The Panzootic Spread of Highly Pathogenic Avian Influenza H5N1 Sublineage 2.3.4.4b: a Critical Appraisal of One Health Preparedness and Prevention." The Lancet. Infectious Diseases 24, no. 12 (2024). https://doi.org/10.1016/S1473-3099(24)00438-9.

Koopmans, Marion P G, et al. "The Panzootic Spread of Highly Pathogenic Avian Influenza H5N1 Sublineage 2.3.4.4b: a Critical Appraisal of One Health Preparedness and Prevention." The Lancet. Infectious Diseases, vol. 24, no. 12, 2024. Stacks. https://doi.org/10.1016/S1473-3099(24)00438-9.
Export RIS Citation Information. TY - Journal Article AU - Koopmans, Marion P G AU - Behravesh, Casey Barton AU - Cunningham, Andrew A AU - Adisasmito, Wiku B AU - Almuhairi, Salama AU - Bilivogui, Pépé AU - Bukachi, Salome A AU - Casas, Natalia AU - Becerra, Natalia Cediel AU - Charron, Dominique F AU - Chaudhary, Abhishek AU - Zanella, Janice R Ciacci AU - Dar, Osman AU - Debnath, Nitish AU - Dungu, Baptiste AU - Farag, Elmoubasher AU - Gao, George F AU - Khaitsa, Margaret AU - Machalaba, Catherine AU - Mackenzie, John S AU - Markotter, Wanda AU - Mettenleiter, Thomas C AU - Morand, Serge AU - Smolenskiy, Vyacheslav AU - Zhou, Lei AU - Hayman, David T S AB - Changes in the epidemiology and ecology of H5N1 highly pathogenic avian influenza are devastating wild bird and poultry populations, farms and communities, and wild mammals worldwide. Having originated in farmed poultry, H5N1 viruses are now spread globally by wild birds, with transmission to many mammal and avian species, resulting in 2024 in transmission among dairy cattle with associated human cases. These ecological changes pose challenges to mitigating the impacts of H5N1 highly pathogenic avian influenza on wildlife, ecosystems, domestic animals, food security, and humans. H5N1 highly pathogenic avian influenza highlights the need for One Health approaches to pandemic prevention and preparedness, emphasising multisectoral collaborations among animal, environmental, and public health sectors. Action is needed to reduce future pandemic risks by preventing transmission of highly pathogenic avian influenza among domestic and wild animals and people, focusing on upstream drivers of outbreaks, and ensuring rapid responses and risk assessments for zoonotic outbreaks. Political commitment and sustainable funding are crucial to implementing and maintaining prevention programmes, surveillance, and outbreak responses. AB - Author manuscript AN - cdc:262053 C4 - PMC12096394 DO - https://doi.org/10.1016/S1473-3099(24)00438-9 IS - 12 J2 - The Lancet. Infectious Diseases KW - Influenza in Birds KW - Animals, Wild KW - Zoonoses KW - Animals KW - One Health KW - Humans KW - Disease Outbreaks KW - Influenza A Virus, H5N1 Subtype KW - Poultry KW - Birds KW - Influenza, Human KW - Animals KW - Humans KW - Influenza A Virus, H5N1 Subtype KW - Influenza in Birds KW - One Health KW - Influenza, Human KW - Birds KW - Animals, Wild KW - Zoonoses KW - Poultry KW - Disease Outbreaks LA - eng PY - 2024 T2 - The Lancet. Infectious Diseases T2 - The Lancet. Infectious Diseases, 2024, v. 24, no. 12 TI - The Panzootic Spread of Highly Pathogenic Avian Influenza H5N1 Sublineage 2.3.4.4b: a Critical Appraisal of One Health Preparedness and Prevention. VL - 24 UR - https://stacks.cdc.gov/view/cdc/262053 ER -
Cross-Site Evaluation of Alcohol Screening and Brief Intervention Implementation Programs in Healthcare Systems Serving Individuals of Reproductive Age.

Vendetti, Janice ;

Bangham, Candice

April 2025 | Substance Use & Addiction Journal, 2025, v. 46, no. 2

With US Centers for Disease Control and Prevention funding, from 2018 to 2022, 4 large healthcare systems (n = 53 health centers across 7 states) serving people of reproductive age trained staff and provided implementation support for alcohol screening and brief intervention (SBI). This cross-site evaluation explores each healthcare system's implem ...

10/10/2026

Supporting Files

Title : Cross-Site Evaluation of Alcohol Screening and Brief Intervention Implementation Programs in Healthcare Systems Serving Individuals of Reproductive Age. Personal Author(s) : Vendetti, Janice;Bangham, Candice;Riba, Melissa;Whitmore, Corrie;Gallucci, Karen Steinberg;Hanson, Bridget L.;Greece, Jacey A.; Published Date : April 2025 Pages in Document : 461-475 (25 pdf pages) Source : Substance Use & Addiction Journal, 2025, v. 46, no. 2 DOI : https://doi.org/10.1177/29767342241267074 Journal Title : Substance Use & Addiction Journal
Vendetti, J., Bangham, C., Riba, M., Whitmore, C., Gallucci, K. S., Hanson, B. L., & Greece, J. A. (2025). Cross-Site Evaluation of Alcohol Screening and Brief Intervention Implementation Programs in Healthcare Systems Serving Individuals of Reproductive Age. Substance Use & Addiction Journal, 46(2). https://doi.org/10.1177/29767342241267074

Vendetti, Janice, Candice Bangham, Melissa Riba, Corrie Whitmore, Karen Steinberg Gallucci, Bridget L. Hanson, and Jacey A. Greece. "Cross-Site Evaluation of Alcohol Screening and Brief Intervention Implementation Programs in Healthcare Systems Serving Individuals of Reproductive Age." Substance Use & Addiction Journal 46, no. 2 (2025). https://doi.org/10.1177/29767342241267074.

Vendetti, Janice, et al. "Cross-Site Evaluation of Alcohol Screening and Brief Intervention Implementation Programs in Healthcare Systems Serving Individuals of Reproductive Age." Substance Use & Addiction Journal, vol. 46, no. 2, 2025. Stacks. https://doi.org/10.1177/29767342241267074.
Export RIS Citation Information. TY - Journal Article AU - Vendetti, Janice AU - Bangham, Candice AU - Riba, Melissa AU - Whitmore, Corrie AU - Gallucci, Karen Steinberg AU - Hanson, Bridget L. AU - Greece, Jacey A. AB - With US Centers for Disease Control and Prevention funding, from 2018 to 2022, 4 large healthcare systems (n = 53 health centers across 7 states) serving people of reproductive age trained staff and provided implementation support for alcohol screening and brief intervention (SBI). This cross-site evaluation explores each healthcare system's implementation approach to implement SBI, reduce excessive alcohol use, and prevent prenatal alcohol exposure (PAE) and fetal alcohol spectrum disorders. AB - The SBIRT (Screening, Brief Intervention, and Referral to Treatment) Program Matrix framed the multilevel strategies to implement alcohol SBI programs from 2018 to 2022. Qualitative and quantitative data sources examined outcomes, guided by one logic model, through systems-level process data and provider-level performance metrics. Data analyses utilized frequencies and means for quantitative data and themes for qualitative data according to an established framework. AB - Successful approaches within systems included using electronic health records, flexible implementation and workflow protocols, customized training and technical assistance programs, quality assurance feedback loops, and stakeholder buy-in. Centralized management structures were efficient in standardizing implementation across health centers. Decentralized management structures used tailored approaches, enhancing provider/staff SBI acceptance. Across systems, 1259 staff (eg, clinicians, medical assistants) were trained to provide alcohol SBI services and reported pre-post training increases in self-efficacy in performing brief intervention; skills in PAE counseling; and confidence in screening. Fifty-three (48 providing data) health centers implemented alcohol SBI, screening 106 826 patients over the study period with most of the 10 087 patients who screened positive for excessive alcohol use receiving a BI. AB - Maximizing the use of technology, employing flexibility in program delivery, and institutionalizing processes and protocols improved workflow, efficiency, and program reach. Ongoing partnership and stakeholder communication identify areas for ongoing improvement, engagement, and best practices for sustainability around substance use screening, which are essential with increases in substance use since the pandemic. AB - Author manuscript AN - cdc:262052 C4 - PMC11823082 DO - https://doi.org/10.1177/29767342241267074 IS - 2 J2 - Substance Use & Addiction Journal KW - Pregnancy KW - Delivery of Health Care KW - Female KW - Alcoholism KW - Fetal Alcohol Spectrum Disorders KW - Mass Screening KW - Male KW - Program Evaluation KW - Humans KW - Adult KW - Cross-site evaluation KW - alcohol screening and brief intervention KW - substance use screening and brief intervention KW - SBIRT Program Matrix KW - brief intervention and referral to treatment KW - FASD KW - fetal alcohol spectrum disorders KW - screening KW - SBI KW - SBIRT KW - Humans KW - Female KW - Fetal Alcohol Spectrum Disorders KW - Pregnancy KW - Mass Screening KW - Alcoholism KW - Adult KW - Program Evaluation KW - Delivery of Health Care KW - Male LA - eng PY - 2025 T2 - Substance Use & Addiction Journal T2 - Substance Use & Addiction Journal, 2025, v. 46, no. 2 TI - Cross-Site Evaluation of Alcohol Screening and Brief Intervention Implementation Programs in Healthcare Systems Serving Individuals of Reproductive Age. VL - 46 UR - https://stacks.cdc.gov/view/cdc/262052 ER -
Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals With Opioid Use Disorder: a Cohort Study.

Jiang, Xinyi ;

Guy, Gery P.

April 2025 | Substance Use & Addiction Journal, 2025, v. 46, no. 2

Opioid use disorder (OUD) affects millions of individuals each year in the United States. Patient retention in medications for opioid use disorder (MOUD) treatment is suboptimal. This study examines and quantifies the associations between each additional month of buprenorphine or methadone use and nonprescribed opioid use.Data were obtained from an ...

10/10/2026

Supporting Files

Title : Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals With Opioid Use Disorder: a Cohort Study. Personal Author(s) : Jiang, Xinyi;Guy, Gery P.;Dever, Jill A.;Richardson, John S.;Dunlap, Laura J.;Turcios, Didier;Wolicki, Sara Beth;Edlund, Mark J.;Losby, Jan L.; Published Date : April 2025 Pages in Document : 266-279 (26 pdf pages) Source : Substance Use & Addiction Journal, 2025, v. 46, no. 2 DOI : https://doi.org/10.1177/29767342241266038 Journal Title : Substance Use & Addiction Journal
Jiang, X., Guy, G. P., Dever, J. A., Richardson, J. S., Dunlap, L. J., Turcios, D., Wolicki, S. B., Edlund, M. J., & Losby, J. L. (2025). Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals With Opioid Use Disorder: a Cohort Study. Substance Use & Addiction Journal, 46(2). https://doi.org/10.1177/29767342241266038

Jiang, Xinyi, Gery P. Guy, Jill A. Dever, John S. Richardson, Laura J. Dunlap, Didier Turcios, Sara Beth Wolicki, Mark J. Edlund, and Jan L. Losby. "Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals With Opioid Use Disorder: a Cohort Study." Substance Use & Addiction Journal 46, no. 2 (2025). https://doi.org/10.1177/29767342241266038.

Jiang, Xinyi, et al. "Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals With Opioid Use Disorder: a Cohort Study." Substance Use & Addiction Journal, vol. 46, no. 2, 2025. Stacks. https://doi.org/10.1177/29767342241266038.
Export RIS Citation Information. TY - Journal Article AU - Jiang, Xinyi AU - Guy, Gery P. AU - Dever, Jill A. AU - Richardson, John S. AU - Dunlap, Laura J. AU - Turcios, Didier AU - Wolicki, Sara Beth AU - Edlund, Mark J. AU - Losby, Jan L. AB - Opioid use disorder (OUD) affects millions of individuals each year in the United States. Patient retention in medications for opioid use disorder (MOUD) treatment is suboptimal. This study examines and quantifies the associations between each additional month of buprenorphine or methadone use and nonprescribed opioid use. AB - Data were obtained from an 18-month longitudinal, observational cohort study of patients (age ≥ 18 years) treated for OUD. Patients completed a baseline self-reported questionnaire between March 2018 and December 2019 and were asked to complete follow-up questionnaires at approximately 3-, 6-, 12-, and 18-months post-baseline until May 2021. Patients treated with buprenorphine or methadone, without taking other MOUD at least 12 months prior to baseline, were included. Outcomes included past 30-day use of prescription opioids nonmedically, heroin, or illegally made fentanyl. A multivariable, multilevel regression model with a binomial distribution and a logit link was used to estimate adjusted odds ratios (aORs) and 95% confidence intervals (CIs). AB - This study included 353 patients taking buprenorphine (mean [standard deviation, SD] age 39 [11] years; 226 [64%] female), and 785 patients taking methadone (mean [SD] age 42 [12] years; 392 [50%] female). Each additional month of MOUD treatment was associated with a 25% decrease in the odds of past 30-day nonprescribed opioid use for patients taking buprenorphine (aOR [95% CI] = 0.75 [0.68-0.83]), and a 17% decrease for patients taking methadone (aOR = 0.83 [0.79-0.87]). The COVID-19 pandemic (aOR = 9.29 [2.96-29.17]; aOR = 3.19 [1.74-5.86]) and MOUD adverse reaction experiences (aOR = 3.07 [1.11-8.48]; aOR = 2.51 [1.01-6.22]) were significantly associated with higher odds of nonprescribed opioid use among buprenorphine and methadone groups. AB - Among patients treated with buprenorphine or methadone, with each additional treatment month since baseline, those who continued with treatment appeared to be more likely to report 17% to 25% decreased odds of past 30-day nonprescribed opioid use. Our findings can be used by clinicians in the shared decision-making process with patients, emphasizing the value of sustained retention in MOUD. AB - Author manuscript AN - cdc:262051 C4 - PMC11825882 DO - https://doi.org/10.1177/29767342241266038 IS - 2 J2 - Substance Use & Addiction Journal KW - Longitudinal Studies KW - Female KW - Buprenorphine KW - Opioid-Related Disorders KW - COVID-19 KW - Methadone KW - Cohort Studies KW - Analgesics, Opioid KW - Male KW - Middle Aged KW - Humans KW - Time Factors KW - Adult KW - Opiate Substitution Treatment KW - opioid use disorder KW - buprenorphine KW - methadone KW - nonprescribed opioid use KW - additional treatment month of Medications for Opioid Use Disorder KW - Adult KW - Female KW - Humans KW - Male KW - Middle Aged KW - Analgesics, Opioid KW - Buprenorphine KW - Cohort Studies KW - COVID-19 KW - Longitudinal Studies KW - Methadone KW - Opiate Substitution Treatment KW - Opioid-Related Disorders KW - Time Factors LA - eng PY - 2025 T2 - Substance Use & Addiction Journal T2 - Substance Use & Addiction Journal, 2025, v. 46, no. 2 TI - Association Between Length of Buprenorphine or Methadone Use and Nonprescribed Opioid Use Among Individuals With Opioid Use Disorder: a Cohort Study. VL - 46 UR - https://stacks.cdc.gov/view/cdc/262051 ER -
An Accelerated PETALUTE MRI Sequence For in Vivo Quantification of Sodium Content in Human Articular Cartilage at 3T.

Villarreal, Cameron X. ;

Shen, Xin

March 1, 2025 | Skeletal Radiology, 2025, v. 54, no. 3

In this work, we evaluate the sodium magnetic resonance imaging (MRI) capabilities of a three-dimensional (3D) dual-echo ultrashort echo time (UTE) sequence with a novel rosette petal trajectory (PETALUTE), in comparison to the 3D density-adapted (DA) radial spokes UTE sequence in human articular cartilage in the knee.We scanned five healthy subjec ...

10/10/2026

Supporting Files

Title : An Accelerated PETALUTE MRI Sequence For in Vivo Quantification of Sodium Content in Human Articular Cartilage at 3T. Personal Author(s) : Villarreal, Cameron X.;Shen, Xin;Alhulail, Ahmad A.;Buffo, Nicholas M.;Zhou, Xiaopeng;Pogue, Evan;Özen, Ali Caglar;Chiew, Mark;Sawiak, Stephen;Emir, Uzay;Chan, Deva D.; Published Date : March 1, 2025 Pages in Document : 601-610 (17 pdf pages) Source : Skeletal Radiology, 2025, v. 54, no. 3 DOI : https://doi.org/10.1007/s00256-024-04774-5 Journal Title : Skeletal Radiology
Villarreal, C. X., Shen, X., Alhulail, A. A., Buffo, N. M., Zhou, X., Pogue, E., Özen, A. C., Chiew, M., Sawiak, S., Emir, U., & Chan, D. D. (2025). An Accelerated PETALUTE MRI Sequence For in Vivo Quantification of Sodium Content in Human Articular Cartilage at 3T. Skeletal Radiology, 54(3). https://doi.org/10.1007/s00256-024-04774-5

Villarreal, Cameron X., Xin Shen, Ahmad A. Alhulail, Nicholas M. Buffo, Xiaopeng Zhou, Evan Pogue, and Ali Caglar Özen, et al.. "An Accelerated PETALUTE MRI Sequence For in Vivo Quantification of Sodium Content in Human Articular Cartilage at 3T." Skeletal Radiology 54, no. 3 (2025). https://doi.org/10.1007/s00256-024-04774-5.

Villarreal, Cameron X., et al. "An Accelerated PETALUTE MRI Sequence For in Vivo Quantification of Sodium Content in Human Articular Cartilage at 3T." Skeletal Radiology, vol. 54, no. 3, 2025. Stacks. https://doi.org/10.1007/s00256-024-04774-5.
Export RIS Citation Information. TY - Journal Article AU - Villarreal, Cameron X. AU - Shen, Xin AU - Alhulail, Ahmad A. AU - Buffo, Nicholas M. AU - Zhou, Xiaopeng AU - Pogue, Evan AU - Özen, Ali Caglar AU - Chiew, Mark AU - Sawiak, Stephen AU - Emir, Uzay AU - Chan, Deva D. AB - In this work, we evaluate the sodium magnetic resonance imaging (MRI) capabilities of a three-dimensional (3D) dual-echo ultrashort echo time (UTE) sequence with a novel rosette petal trajectory (PETALUTE), in comparison to the 3D density-adapted (DA) radial spokes UTE sequence in human articular cartilage in the knee. AB - We scanned five healthy subjects using a 3D dual-echo PETALUTE acquisition and two comparable implementations of 3D DA-radial spokes acquisitions, one matching the number of k-space projections (Radial - Matched Spokes) and the other matching the total number of samples (Radial - Matched Samples) acquired in k-space. AB - The PETALUTE acquisition enabled equivalent sodium quantification in articular cartilage volumes of interest (168.8 ± 29.9 mM, mean ± standard deviation) to those derived from the 3D radial acquisitions (171.62 ± 28.7 mM and 149.8 ± 22.2 mM, respectively). We achieved a 41% shorter scan time of 2:06 for 3D PETALUTE, compared to 3:36 for 3D radial acquisitions. We also evaluated the feasibility of further acceleration of the PETALUTE sequence through retrospective compressed sensing with 2 × and 4 × acceleration of the first echo and showed structural similarity of 0.89 ± 0.03 and 0.87 ± 0.03 when compared to non-retrospectively accelerated reconstruction. AB - We demonstrate improved scan time with equivalent performance using a 3D dual-echo PETALUTE sequence compared to the 3D DA-radial sequence for sodium MRI of articular cartilage. AB - Author manuscript AN - cdc:262050 C4 - PMC11769871 DO - https://doi.org/10.1007/s00256-024-04774-5 IS - 3 J2 - Skeletal Radiology KW - Retrospective Studies KW - Adolescent KW - Magnetic Resonance Imaging KW - Female KW - Knee Joint KW - Sodium KW - Male KW - Healthy Volunteers KW - Humans KW - Young Adult KW - Adult KW - Cartilage, Articular KW - Sodium MRI KW - Ultrashort echo time KW - Fixed charge density KW - Articular cartilage KW - Humans KW - Male KW - Female KW - Adolescent KW - Young Adult KW - Adult KW - Healthy Volunteers KW - Cartilage, Articular KW - Sodium KW - Magnetic Resonance Imaging KW - Knee Joint KW - Retrospective Studies LA - eng PY - 2025 T2 - Skeletal Radiology T2 - Skeletal Radiology, 2025, v. 54, no. 3 TI - An Accelerated PETALUTE MRI Sequence For in Vivo Quantification of Sodium Content in Human Articular Cartilage at 3T. VL - 54 UR - https://stacks.cdc.gov/view/cdc/262050 ER -
Evaluation of a Passive Back-support Exoskeleton During In-bed Patient Handling Tasks.

Zheng, Liying ;

Alluri, Chandra Sekhar Varma

December 2024 | International Journal of Occupational Safety and Ergonomics: JOSE, 2024, v. 30, no. 4

This study evaluated the effects of a back-support exoskeleton on the trunk and hip joint angles, lower back muscle activity and heart rate during four patient handling tasks: assisting a patient from sitting to lying, laterally repositioning the patient and turning the patient in two directions. Eight participants performed these tasks with and wi ...

10/10/2026

Supporting Files

Title : Evaluation of a Passive Back-support Exoskeleton During In-bed Patient Handling Tasks. Personal Author(s) : Zheng, Liying;Alluri, Chandra Sekhar Varma;Hawke, Ashley L.;Hwang, Jaejin; Published Date : December 2024 Pages in Document : 1226-1233 (18 pdf pages) Source : International Journal of Occupational Safety and Ergonomics: JOSE, 2024, v. 30, no. 4 DOI : https://doi.org/10.1080/10803548.2024.2383077 Journal Title : International Journal of Occupational Safety and Ergonomics: JOSE
Zheng, L., Alluri, C. S. V., Hawke, A. L., & Hwang, J. (2024). Evaluation of a Passive Back-support Exoskeleton During In-bed Patient Handling Tasks. International Journal of Occupational Safety and Ergonomics: JOSE, 30(4). https://doi.org/10.1080/10803548.2024.2383077

Zheng, Liying, Chandra Sekhar Varma Alluri, Ashley L. Hawke, and Jaejin Hwang. "Evaluation of a Passive Back-support Exoskeleton During In-bed Patient Handling Tasks." International Journal of Occupational Safety and Ergonomics: JOSE 30, no. 4 (2024). https://doi.org/10.1080/10803548.2024.2383077.

Zheng, Liying, et al. "Evaluation of a Passive Back-support Exoskeleton During In-bed Patient Handling Tasks." International Journal of Occupational Safety and Ergonomics: JOSE, vol. 30, no. 4, 2024. Stacks. https://doi.org/10.1080/10803548.2024.2383077.
Export RIS Citation Information. TY - Journal Article AU - Zheng, Liying AU - Alluri, Chandra Sekhar Varma AU - Hawke, Ashley L. AU - Hwang, Jaejin AB - This study evaluated the effects of a back-support exoskeleton on the trunk and hip joint angles, lower back muscle activity and heart rate during four patient handling tasks: assisting a patient from sitting to lying, laterally repositioning the patient and turning the patient in two directions. Eight participants performed these tasks with and without the exoskeleton. Results demonstrated a significant reduction in the lower back muscle activity, but less pronounced effects for other tasks involving minimal trunk flexion. Hip flexion angles were reduced for all tasks when the exoskeleton was worn. The amount of reduction in the muscle activity and changes in the trunk and hip angles varied by task. The exoskeleton did not affect the heart rate across all tasks. The exoskeleton appeared to be more effective in tasks requiring substantial trunk flexion, indicating its potential benefits for reducing lower back muscle strain during such activities. AB - Author manuscript AN - cdc:262049 C4 - PMC11779591 DO - https://doi.org/10.1080/10803548.2024.2383077 IS - 4 J2 - International Journal of Occupational Safety and Ergonomics: JOSE KW - Range of Motion, Articular KW - Female KW - Posture KW - Heart Rate KW - Exoskeleton Device KW - Electromyography KW - Torso KW - Young Adult KW - Moving and Lifting Patients KW - Back Muscles KW - Male KW - Hip Joint KW - Humans KW - Biomechanical Phenomena KW - Adult KW - patient handling KW - back-support exoskeleton KW - musculoskeletal disorders KW - electromyography KW - heart rate KW - Humans KW - Moving and Lifting Patients KW - Exoskeleton Device KW - Male KW - Heart Rate KW - Adult KW - Hip Joint KW - Back Muscles KW - Female KW - Electromyography KW - Posture KW - Torso KW - Biomechanical Phenomena KW - Young Adult KW - Range of Motion, Articular LA - eng PY - 2024 T2 - International Journal of Occupational Safety and Ergonomics: JOSE T2 - International Journal of Occupational Safety and Ergonomics: JOSE, 2024, v. 30, no. 4 TI - Evaluation of a Passive Back-support Exoskeleton During In-bed Patient Handling Tasks. VL - 30 UR - https://stacks.cdc.gov/view/cdc/262049 ER -
Non-Linkage to Care and Non-Viral Suppression Among Hispanic/Latino Persons by Birthplace and Social Vulnerability-United States, 2021.

Morales, Juliet A. ;

Sumner, Zanetta Gant

October 2025 | Journal of Racial and Ethnic Health Disparities, 2025, v. 12, no. 5

Assessing individual- and community-level factors may help to explain differences among Hispanic/Latino adults with diagnosed HIV not linked to care and without viral suppression in the United States.We analyzed CDC's National HIV Surveillance System data among Hispanic/Latino persons aged ≥ 18 years with HIV diagnosed during 2021 in 47 states and ...

10/10/2026

Supporting Files

Title : Non-Linkage to Care and Non-Viral Suppression Among Hispanic/Latino Persons by Birthplace and Social Vulnerability-United States, 2021. Personal Author(s) : Morales, Juliet A.;Sumner, Zanetta Gant;Hu, Xiaohong;Lyons, Shacara Johnson;Johnson, Anna Satcher; Published Date : October 2025 Pages in Document : 3301-3311 (21 pdf pages) Source : Journal of Racial and Ethnic Health Disparities, 2025, v. 12, no. 5 DOI : https://doi.org/10.1007/s40615-024-02133-7 Journal Title : Journal of Racial and Ethnic Health Disparities
Morales, J. A., Sumner, Z. G., Hu, X., Lyons, S. J., & Johnson, A. S. (2025). Non-Linkage to Care and Non-Viral Suppression Among Hispanic/Latino Persons by Birthplace and Social Vulnerability-United States, 2021. Journal of Racial and Ethnic Health Disparities, 12(5). https://doi.org/10.1007/s40615-024-02133-7

Morales, Juliet A., Zanetta Gant Sumner, Xiaohong Hu, Shacara Johnson Lyons, and Anna Satcher Johnson. "Non-Linkage to Care and Non-Viral Suppression Among Hispanic/Latino Persons by Birthplace and Social Vulnerability-United States, 2021." Journal of Racial and Ethnic Health Disparities 12, no. 5 (2025). https://doi.org/10.1007/s40615-024-02133-7.

Morales, Juliet A., et al. "Non-Linkage to Care and Non-Viral Suppression Among Hispanic/Latino Persons by Birthplace and Social Vulnerability-United States, 2021." Journal of Racial and Ethnic Health Disparities, vol. 12, no. 5, 2025. Stacks. https://doi.org/10.1007/s40615-024-02133-7.
Export RIS Citation Information. TY - Journal Article AU - Morales, Juliet A. AU - Sumner, Zanetta Gant AU - Hu, Xiaohong AU - Lyons, Shacara Johnson AU - Johnson, Anna Satcher AB - Assessing individual- and community-level factors may help to explain differences among Hispanic/Latino adults with diagnosed HIV not linked to care and without viral suppression in the United States. AB - We analyzed CDC's National HIV Surveillance System data among Hispanic/Latino persons aged ≥ 18 years with HIV diagnosed during 2021 in 47 states and the District of Columbia and linked cases via census tracts to the CDC/ATSDR's Social Vulnerability Index (SVI). Adjusted prevalence ratios and 95% confidence intervals for non-linkage to care and non-viral suppression were estimated using Poisson regression model. AB - Among 5,056 Hispanic/Latino adults with HIV diagnosed in 2021, 51.5% were born in the United States, 17.3% in Mexico, 9.2% in Central America, 11.1% in South America, 1.8% in Puerto Rico, 6.8% in Cuba, and 2.4% in the Caribbean. Compared with U.S.-born Hispanic/Latino adults, those born in Mexico and South America had a lower prevalence of non-linkage to care. Hispanic/Latino adults born in Mexico, South America, and the Caribbean (excluding Puerto Rico and Cuba) had a lower prevalence of non-viral suppression, compared with those born in the United States. No significant differences were observed among SVI quartiles for either care outcome. AB - This study aimed to challenge the narrow perspective on HIV care outcomes by examining the impact of birthplace and social vulnerability among Hispanic/Latino adults. To increase HIV care and prevention among Hispanic/Latino persons, research must evaluate health disparities within the group, and efforts are needed to better understand and tailor interventions within the diverse Hispanic/Latino population. AB - Author manuscript AN - cdc:262048 C4 - PMC11836171 DO - https://doi.org/10.1007/s40615-024-02133-7 IS - 5 J2 - Journal of Racial and Ethnic Health Disparities KW - Adolescent KW - White KW - Female KW - Hispanic or Latino KW - Social Vulnerability KW - Male KW - Middle Aged KW - Humans KW - Young Adult KW - Adult KW - HIV Infections KW - HIV KW - Hispanic/Latino KW - social vulnerability KW - birthplace KW - linkage to care KW - viral suppression KW - Humans KW - Adult KW - Male KW - Hispanic or Latino KW - Female KW - HIV Infections KW - Middle Aged KW - Social Vulnerability KW - Young Adult KW - Adolescent KW - White LA - eng PY - 2025 T2 - Journal of Racial and Ethnic Health Disparities T2 - Journal of Racial and Ethnic Health Disparities, 2025, v. 12, no. 5 TI - Non-Linkage to Care and Non-Viral Suppression Among Hispanic/Latino Persons by Birthplace and Social Vulnerability-United States, 2021. VL - 12 UR - https://stacks.cdc.gov/view/cdc/262048 ER -

Previous Page Previous

201 - 220 / 1970

Next Page Next

Found an issue?

Send us an email at: publishinghd@cdc.gov